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Mri Assessment Of Maternal Uteroplacental Circulation In Pregnancy
Abstract
Hypertensive pregnancy disorders (HPD) such as preeclampsia are highly associated with maternal
vascular malperfusion of the placenta, an organ that exchanges nutrients and oxygen between the
maternal circulation and the growing fetus. Adverse pregnancy outcomes are difficult to predict because
there is insufficient understanding of how poor maternal arterial remodeling leads to disease. There is
also a lack of reliable tools to evaluate these changes in early gestation.
The hypothesis of this dissertation was that magnetic resonance imaging (MRI) could noninvasively
evaluate uteroplacental function in vivo through a combination of arterial spin labeling (ASL), 4D flow, and
time-of-flight (TOF) techniques which were already effective in the evalution of other cardiovascular
diseases. These flow and perfusion imaging studies were conducted on human pregnant volunteers in
their second and third trimesters at 1.5T. Many of them were also examined by conventional Doppler
ultrasound (US) and followed through delivery.
Flow-sensitive Alternating Inversion Recovery (FAIR) ASL MRI with background suppression was found to
be feasible in detecting placental perfusion signal despite the presence of motion artifacts. An important
consideration when studying placental ASL was the slow movement of maternal arterial blood in a large
cavity called the intervillous space. This was a unique feature of placental anatomy which distinguished it
from other organs containing capillaries. It became apparent that traditional models to estimate
perfusion from MRI were no longer applicable. In this work, a statistical approach was first developed to
filter out motion artifacts, followed by a coordinate transformation to better represent the lobular
distribution of blood flow in the intervillous space of the placenta. The uterine arteries (UtAs) are the main
maternal blood supply of the placenta and have also long been suspected to be involved in HPD, though
US-based measurements have not yet been found to be highly predictive for widespread clinical use. In
this work, 4D flow MRI enabled visualization of the tortuous UtAs while measuring volumetric flow rate.
Its performance in predicting incidence of preeclampsia and small-for-gestational age births was
comparable to Doppler US. When considering the innovative potential of 4D flow MRI to capture complex
flow dynamics, this validation demonstrated the value of continuing technical development for improving
HPD risk assessment. Furthermore, centerline extraction of the maternal pelvic arteries in TOF MRI, from
the descending aorta to the UtAs and external iliac arteries, provided quantitative metrics to characterize
the geometry including path length and curvature. Pulse wave velocity (PWV) was estimated using path
length by TOF MRI and velocimetry by 2D phase contrast and 4D flow MRI with results showing sensitivity
to differences between UtAs and external iliac arteries. These approaches provided physiological metrics
to explore and characterize the remodeling process of the uteroplacental arteries. This dissertation
demonstrates the feasibility of measuring structure and hemodynamics of the maternal vascular blood
supply using non-contrast MRI that can lead to the more reliable biomarkers of adverse pregnancy
outcomes needed to diagnose and treat HPD.
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ABSTRACT
MRI ASSESSMENT OF MATERNAL UTEROPLACENTAL CIRCULATION IN PREGNANCY
Eileen Hwuang
Walter R. Witschey
John A. Detre
Hypertensive pregnancy disorders (HPD) such as preeclampsia are highly associated with
maternal vascular malperfusion of the placenta, an organ that exchanges nutrients and oxygen
between the maternal circulation and the growing fetus. Adverse pregnancy outcomes are difficult
to predict because there is insufficient understanding of how poor maternal arterial remodeling
leads to disease. There is also a lack of reliable tools to evaluate these changes in early
gestation.
The hypothesis of this dissertation was that magnetic resonance imaging (MRI) could
noninvasively evaluate uteroplacental function in vivo through a combination of arterial spin
labeling (ASL), 4D flow, and time-of-flight (TOF) techniques which were already effective in the
evalution of other cardiovascular diseases. These flow and perfusion imaging studies were
conducted on human pregnant volunteers in their second and third trimesters at 1.5T. Many of
them were also examined by conventional Doppler ultrasound (US) and followed through
delivery.
Flow-sensitive Alternating Inversion Recovery (FAIR) ASL MRI with background suppression was
found to be feasible in detecting placental perfusion signal despite the presence of motion
artifacts. An important consideration when studying placental ASL was the slow movement of
maternal arterial blood in a large cavity called the intervillous space. This was a unique feature of
placental anatomy which distinguished it from other organs containing capillaries. It became
v

apparent that traditional models to estimate perfusion from MRI were no longer applicable. In this
work, a statistical approach was first developed to filter out motion artifacts, followed by a
coordinate transformation to better represent the lobular distribution of blood flow in the
intervillous space of the placenta.
The uterine arteries (UtAs) are the main maternal blood supply of the placenta and have also long
been suspected to be involved in HPD, though US-based measurements have not yet been found
to be highly predictive for widespread clinical use. In this work, 4D flow MRI enabled visualization
of the tortuous UtAs while measuring volumetric flow rate. Its performance in predicting incidence
of preeclampsia and small-for-gestational age births was comparable to Doppler US. When
considering the innovative potential of 4D flow MRI to capture complex flow dynamics, this
validation demonstrated the value of continuing technical development for improving HPD risk
assessment.
Furthermore, centerline extraction of the maternal pelvic arteries in TOF MRI, from the
descending aorta to the UtAs and external iliac arteries, provided quantitative metrics to
characterize the geometry including path length and curvature. Pulse wave velocity (PWV) was
estimated using path length by TOF MRI and velocimetry by 2D phase contrast and 4D flow MRI
with results showing sensitivity to differences between UtAs and external iliac arteries. These
approaches provided physiological metrics to explore and characterize the remodeling process of
the uteroplacental arteries.
This dissertation demonstrates the feasibility of measuring structure and hemodynamics of the
maternal vascular blood supply using non-contrast MRI that can lead to the more reliable
biomarkers of adverse pregnancy outcomes needed to diagnose and treat HPD.
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CHAPTER 1: OVERVIEW OF THE DISSERTATION
1.1 Clinical Relevance and Motivation to Address Hypertensive Pregnancy
Disorders
Despite advances in obstetric care, preeclampsia remains one of the leading pregnancy
complications in the world. Preeclampsia is a common type of hypertensive pregnancy disorder
(HPD), a syndrome surrounding high blood pressure during gestation. More severe cases may
present as a multi-system disorder including pulmonary edema, cerebral disturbances, and
thrombocytopenia [1]. Rates of preeclampsia in the United States have been on the rise, with
those delivering in 2003 at 6.7-fold increased risk compared to those delivering in 1980 [2].
Among inpatient deliveries in the United States, preeclampsia/eclampsia cases have risen 21%
from 2005 to 2014 [3] (Figure 1). It is estimated that 3.4% of pregnancies involve preeclampsia
[2]. HPD may occur in conjunction with intrauterine growth restriction (IUGR), defined as a fetus
that has not fully attained its growth potential. HPD is known to have critical long-term effects not
only in terms of fetal morbidity and mortality (accounting for 4-9% of stillbirths worldwide [4]) but
also increased risk of maternal death (accounting for 15.9% of maternal deaths in the United
States [5]) and maternal chronic illness, especially cardiovascular disease [6].

1

Figure 1 Rates of preeclampsia/eclampsia from 2005-2014 among inpatient deliveries in
the United States [3]
Currently, the most effective way to stop the damaging effects of preeclampsia is to deliver the
baby [7], but this has to be balanced with maximizing the gestational time for fetal development
as there are also risks of preterm birth. Therefore, anti-hypertensive medications are often
administered to protect the mother from hypertensive complication during or immediately after
pregnancy. For example, aspirin is known to decrease blood pressure by inhibiting platelet
activation and to improve endothelial dysfunction by allowing for increased vasodilation [8, 9].
Another example is calcium supplementation, which can relax vascular smooth muscle and inhibit
vasoconstriction [10, 11]. Additionally, magnesium sulfate can be prescribed to prevent eclamptic
seizures.
More research is needed to better understand molecular targets for treating adverse pregnancy
outcomes. Fetal safety and medication use during pregnancy is understudied as most clinical
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trials have been conducted at the exclusion of pregnant women [12, 13]. However, more and
more women are on medications for chronic conditions during the period when they do not know
that they are pregnant [13]. There are too few studies on the pharmacokinetic patterns of drug
delivery and absorption in pregnant women. Therefore, there is a need for new technologies to
assess the in vivo efficacy of drugs in real-time and better understand physiological changes in
pregnancy that would have a critical effect on dosing [13].
Much research has gone into developing and testing screening methods for preeclampsia to
identify patients who would benefit the most from treatment such as early delivery [7, 14] and
anti-hypertensive therapy [9]. When screening with maternal factors and biochemical factors
alone, only 40% of preeclamptic women were identified [15]. One of the most recent and
promising first-trimester screening studies for preeclampsia consisted of a combination of
maternal history, mean arterial pressure, uterine artery pulsatility index, and placental growth
factor. It reported a detection rate for preterm preeclampsia of 67% with a screen-positive rate of
10% [16, 17]. However, multivariate models such as these are too complex for widespread
clinical adoption so far [18].
These gaps in obstetric treatment and screening tools were brought to the forefront in 2014 when
the National Institutes of Health identified the placenta as “the least understood human organ”
[19]. This sparked a collective initiative to investigate the development, structure, and function of
the placenta.
The goal of the Human Placenta Project is to develop technologies that would be able to evaluate
the placenta safely, non-invasively, and in real-time. Given the growing body of evidence that
placental abnormalities contribute to adverse pregnancy outcomes including HPD, the hope is to
provide new avenues of patient care and improve the lifelong health of both mother and baby. A
multidisciplinary team at the University of Pennsylvania responded to this call and was awarded a
grant from the Human Placenta Project to investigate placental development by harnessing
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existing multi-modality imaging tools. This consisted of: 1) ultrasound of structure and blood flow,
2) MRI of placental oxygenation, flow, and perfusion, and 3) near-infrared spectroscopy of
pregnant women.

1.2 Current Technological Limitations in Uteroplacental Flow and Perfusion
The limited understanding of the pathophysiology of HPD is largely attributed to the lack of
suitable technologies to investigate human uteroplacental hemodynamics. The current primary
method for measuring uterine artery and placental blood flow is Doppler ultrasound (US) (Figure
2). While it does provide a real-time reading of velocity and is a portable and safe technology for
obstetrics, it has a limited field of view and spatial resolution, making it difficult to reliably measure
the cross-sectional area for volumetric flow in the tortuous uterine arteries and spiral arteries.
An alternative method for non-invasively measuring blood flow is MRI, which allows for multiple
contrast mechanisms. Time-of-flight (TOF) angiography provides a large field-of-view and
sufficient spatial resolution to visualize both uterine arteries, allowing quantification of vessel
morphometry and cross-sectional areas. Phase contrast MRI has been used to measure blood
flow in the uterine arteries, but 2-dimensional (2D) methods [20, 21] are limited because they
require the imaging plane be oriented perpendicular to the vessel, a difficult task in the small and
tortuous uterine arteries. 4D flow methods can potentially address this limitation by measuring
flow dynamics in 3-dimensional space [22]. Arterial spin labeling (ASL) MRI has been used to
measure placental perfusion at the microvascular level [23, 24] though the technique is
vulnerable to motion artifacts and traditional signal models may not be accurate for the unique
arteriovenous structure of the placenta.
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Figure 2 Example Doppler US of the right uterine artery in a representative subject

1.3 Research Objectives
The research described in this dissertation aims to address the need for better understanding of
the pathophysiology of HPD by developing imaging and computational technologies for
investigating the hemodynamics of pregnancy. The long-term vision is that improved knowledge
about the maternal cardiovascular system can lead to better clinical management and a reduction
in adverse pregnancy outcomes worldwide.
In support of this endeavor, this dissertation presents the following contributions:
•

Development of ASL MRI acquisition and processing strategies for measuring placental
perfusion

•

Application of 4D flow MRI and TOF MRI for measuring uterine artery flow and pulse
wave velocity in 2

•
5

nd

rd

and 3 trimester human pregnancy

Validation of 4D flow MRI and its association with pregnancy outcomes

•

Exploration of potential physiological biomarkers of HPD by estimating uterine artery path
length, curvature, and pulse wave velocity from MRI data.

1.4 Dissertation Overview
This dissertation is organized as follows.
Chapter 2 begins with a description of the normal cardiovascular system followed by an
explanation of the anatomical and functional changes that occur during pregnancy and HPD.
Chapter 3 provides a background on existing non-invasive technologies to assess cardiovascular
disease.
In Chapter 4, an arterial spin labeling (ASL) MRI approach to measuring spiral artery function is
described. Challenges to measurement accuracy by motion artifacts and the unique vascular
structure of the placenta are addressed.
Chapter 5 presents non-invasive imaging of the uterine artery using ultrasound, 4D flow MRI, and
TOF MRI.
Chapter 6 describes the assessment of HPD with non-invasive imaging and presents results from
the association between 4D flow MRI and pregnancy outcomes.
In Chapter 7, feasibility of estimating path length and curvature from centerline extraction of TOF
MRI of the maternal pelvic arteries is demonstrated. Also, feasibility of estimating pulse wave
velocity from TOF and 4D flow MRI is shown. The potential utility of these parameters to test
hypotheses about HPD physiology and pathophysiology is discussed.
Chapter 8 summarizes the dissertation with concluding remarks about MRI in pregnancy,
limitations, and future directions.
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CHAPTER 2: CARDIOVASCULAR SYSTEM AND PREGNANCY
2.1 Overview of the normal function of the cardiovascular system
The cardiovascular system is important for bringing oxygen and nutrients to tissues throughout
the body and clearing metabolic waste. It also plays a critical role in regulating body temperature,
endocrine function, and compensating for various physiologic conditions. It is comprised of a
pump and a network of vessels to carry blood throughout the system [25]. The heart generates a
pumping force on the blood with four chambers: left atrium, left ventricle, right atrium, and right
ventricle. Oxygenated blood from the lungs enters the left atrium, then enters the left ventricle.
The thick, muscular walls of the left ventricle allow it to pump blood into the aorta and on to the
rest of the body. As peripheral tissues absorb and metabolize the oxygen delivered, the blood
returning to the heart has reduced oxygen when it enters the right atrium and right ventricle. The
right ventricle is also surrounded by muscle and generates enough force to deliver blood through
the lungs to be reoxygenated before going back to the left atrium to continue the cardiac cycle.
The peripheral vasculature is a network of arteries and veins to circulate blood throughout the
body. The diameter of the vessels decreases from aorta to arteriole to capillary, and progressively
increases again from venule to vein to vena cava. All vessels are internally lined with a thin layer
of endothelial cells. In capillaries, this layer allows for transport of molecules between the vessels
and the interstitium through diffusion, pore filtration, and pinocytosis [25]. Venules have an
endothelial layer surrounded by fibrous tissue. The vessel walls of the aorta, arteries, arterioles,
veins, and vena cava have layers of elastin, smooth muscle, and fibrous tissue surrounding the
endothelial layer. However, the arterial vessels (aorta, arteries, arterioles) tend to have thicker
walls compared to the venous vessels (venules, veins, vena cava) in order to sustain higher
blood pressures and velocities (Fig. 3).
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Figure 3 Description of vessel geometrical properties and tissue components in various
blood vessel segments [25]. Note: Cross-sectional areas are not drawn to scale.

2.1.1 Hemodynamics of the arterial system
Hemodynamics is the study of the fluid properties of blood, the manner in which it moves through
blood vessels, and how external pressures affect its movement. The rate at which blood is
propelled from the left ventricle to the rest of the body is called the cardiac output. It is reported
in mL/min and is calculated as a product of stroke volume (volume of blood ejected in one left
-1

ventricular contraction, mL) and heart rate (number of beats per minute, min ). The human body
has mechanisms in place to adapt to the body’s demands. For example, at rest skeletal muscle
receives about 20% of the cardiac output but during exercise it can receive up to 80% [26].
The typical pressure of outflowing blood from the left ventricle, called mean arterial pressure, is
about 100 mmHg and by the time blood returns to the right atrium, its pressure, referred to as
right atrial pressure, is 2-6 mmHg [27]. This positive pressure difference is the primary driving
factor of blood along blood vessels throughout the system. The systemic vascular resistance,
reported in mmHg/mL/min, determines how much pressure is required to produce a given cardiac
output. According to Darcy’s law, cardiac output is directly proportional to this pressure difference
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by a factor of 1/systemic vascular resistance, i.e. cardiac output = (aortic pressure – right atrial
pressure)/systemic vascular resistance.
Besides pressure, there are other sources of fluid energy driving blood flow. Bernoulli’s equation
states that the mechanical energy of a unit volume of blood is additionally driven by
potential/gravitational energy and kinetic energy:
constant = #$ + &'ℎ + &) *,

where !" =aortic pressure, ! =density of blood, g=gravitational acceleration, h=height, and
v=velocity.
In the human circulatory system, the terminal arteries and arterioles are known to have the
highest resistance because the pressure drop is the largest across those segments compared to
other parts of the vascular network. This phenomenon can also be understood at the level of a
single vessel; when blood is flowing through a cylindrical pipe, narrowing the lumen (at the same
pressure and height) would decrease the flow (Darcy’s Law) but increase the velocity (Bernoulli’s
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equation). The Hagen-Poiseulle equation states that the resistance R=8µL/(πr ), where µ = fluid
viscosity, L = length of pipe, and r = radius of pipe, which means that reducing the radius by a
factor of 2 increases the resistance to flow by a factor of 16!
The shape of the velocity profile of blood flow in a vessel is a strong reflection of its underlying
hemodynamics. Most blood flow in vessels is laminar, meaning that the velocity profile is
2

2

parabolic, i.e. v(r) = vmax*(1-r )/R , where r = radial position and R = pipe radius. Velocity at the
vessel wall is zero because of the molecular cohesive forces that restrict movement. This is often
called the zero-slip condition. Velocity is the highest at the center of the vessel because of
greatest distance from the molecular cohesive forces at the vessel wall. In locations such as the
ventricles and near stenoses, the velocity profile is not laminar but turbulent. This means that the
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flow pattern is more chaotic, the degree of which is described by the Reynolds number: Re =
νDρ/η, where ν = velocity, D = vessel diameter, ρ = fluid density, and η = fluid viscosity. For
different combinations of vessel geometry and flow conditions, there is a corresponding critical
Reynolds number that serves as a threshold value beyond which turbulent flow occurs. For
example, for uniform steady flow in a straight pipe the critical Re is approximately 2000. In blood
vessels, flow is often laminar as Re is often below 2000 and can even reach as low as ~0.5.
Even though there is typically no velocity at the wall, the moving blood still exerts shear stress by
tugging on the glycocalyx, a layer of polymers coating the endothelium. Wall shear stress
functions as a signal to the endothelium to secrete molecules such as nitric oxide to vasodilate
the vessel and reduce the wall shear stress. However, it is frequently the case especially in
clinical settings that wall shear stress is ignored when calculating velocity. This is called “plug
flow,” where the velocity profile is approximated as an average single value throughout the vessel
and flow rate is computed multiplying the average velocity by cross-sectional area.
The hemodynamic concepts described thus far consider blood flow, pressure, and resistance at
steady state. In actuality, the cyclical manner in which the heart contracts and relaxes produces
pulsatile aortic pressure and cardiac output. The degree to which the pulsatile nature of pressure
and flow is dampened in the rest of the body is based on the interaction between resistance and
compliance of the arteries [28]. The Windkessel model [29, 30] has often been used to describe
how pulsatile flow from the heart is dampened by the time it reaches the end organs. It states that
blood pressure in the cardiovascular system is dependent on two parameters, resistance and
compliance. The resistance is largely based on the radii of small arteries and arterioles. The
compliance is largely based on the elasticity of large arteries. Arterial stiffness is often observed
in hypertensive patients in whom the vessel compliance is very low and/or resistance is very high
[31-34].
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Research has shown that measuring pulse wave velocity, the speed at which a pressure wave
generated by a heartbeat is transmitted throughout the cardiovascular system, can be useful for
identifying high-risk patients for various cardiovascular diseases [35-39]. This is because a
consequence of rigid arterial walls is that pulse wave velocity increases compared to less rigid
arterial walls. This is approximated by the Moens-Korteweg equation

!"# =

%&

,

'()

where h=wall thickness, E=elastic modulus, r=radius, and ! =density of blood. Fig. 4 shows how
PWV increases with age with one of the contributing factors being increasing elastic modulus.

Figure 4 A) Plot of elastic modulus (Ep) as age increases and B) plot of PWV as age
increases. Solid circles (•) denote proximal thoracic aorta and open circles (¡) denote
proximal pulmonary artery [28, 40]
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2.1.2 Hemodynamics of the venous system
After oxygenated arterial blood is metabolized by end organs, deoxygenated blood is returned
back to the heart via the venous system. Veins and venules are notable for their thin, distensible
walls and are able to contain a large volume of blood with a small increase in pressure. In fact,
they can be up to 50x more compliant than arteries and arterioles [26]. Venous pressure tends to
be negative above heart level. Central venous pressure, an estimate of right atrial pressure, is
typically measured noninvasively by having the patient lie semirecumbent supine and locating the
point of collapse of the jugular vein. This is roughly the location where the transmural pressure is
nearly 0, i.e. the blood pressure matches atmospheric pressure. The distance between the
collapse of the jugular vein and the manubriosternal angle plus the distance between the
manubriosternal angle and the right atrium (estimated to be 5 cm) is the central venous pressure
in cm blood or converted to cmH2O [26].
While venous blood flows continuously, the effect of gravity does increase pressure in the lower
part of the body below the heart and decrease central venous pressure, a phenomenon called
orthostasis. To counterbalance this effect, skeletal muscle acts as a pump to contract and
compress veins, which contain valves that close and prevent retrograde flow of blood away from
the heart. When the muscle relaxes, the valves open and venous blood flows toward the heart.
During aging, malfunctioning valves can cause varicose veins and leg ulcers from abnormally
high venous pressure in the lower extremities. Respiration also encourages venous return during
inspiration, when intrathoracic pressure decreases and intraabdominal pressure increases.
Expiration creates the opposite effect and reduces intrathoracic venous blood flow [26].

2.1.3 Fluid properties of blood
Blood is made up of red blood cells, white blood cells, platelets, plasma, and nutritional
macromolecules. The bone marrow houses pluripotent stem cells that self-replicate to form
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specialized cells that enter the circulating blood. These specialized cells include erythrocytes,
leukocytes, and megakaryocytes [25].
Erythrocytes are commonly known as red blood cells. They contain hemogloblin protein
molecules that bind reversibly to oxygen molecules based on pH, temperature, and concentration
of 2.3-diphosphoglycerate. This is important for transporting oxygen from the lungs to other
organs. Aberrations in the protein structure of hemoglobin and in the concentration of
erythropoietin (erythrocyte-producing hormone) in the human body can affect the availability of
oxygen for metabolism.
Leukocytes are commonly known as white blood cells. They are primarily responsible for helping
the body fight against infection through the removal of foreign material and cellular debris.
Megakaryocytes in the bone marrow divide into small fragments called platelets that enter
circulating blood. Platelets play an important role in coagulation and cell repair when there is
bleeding. Blood also contains macromolecules such as proteins, carbohydrates, and fatty acids
suspended in a solution called plasma. These nutrients are transported through the circulation to
various parts of the body for metabolism or storage.
The constituents of blood also have an effect on hemodynamics. Most discussions of
hemodynamics in cardiovascular physiology approximate blood as a homogeneous,
incompressible, Newtonian fluid. This simplifies the equations used to describe hemodynamics
and renders them practical for clinical and research purposes. However, blood is actually nonhomogeneous, compressible, and non-Newtonian because approximating the fluid properties of
blood can sometimes lead to non-negligible errors.
For reference, the viscosity of pure water remains constant with changes in shear rate (i.e. a
Newtonian fluid) and is therefore classically determined by Poiseulle’s Law. In contrast, blood is a
suspension of various cells, molecules, and other biological constituents and its viscosity changes
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with shear rate (i.e. a non-Newtonian fluid). For this reason, Poiseulle’s Law is not accurate in
characterizing blood. Specifically, blood is a shear-thinning fluid because viscosity decreases with
increasing shear rate. The Fåhræus-Lindqvist phenomenon describes how blood viscosity is
lower in vessels with diameters <0.3 mm (size of small arterioles, venules, and capillaries) [41]. In
these small vessels, high flow rate is associated with red blood cells tending to flow in the axial
part of the velocity profile while the rest of the blood such as plasma have lower flow rates near
the vessel wall. This effect is modulated by the concentration of fibrinogen and the flexibility of red
blood cells [25].

2.2 Systemic regulation of blood flow and normal pregnancy physiology
The cardiovascular changes that occur in normal human pregnancy are significant and
comprehensive. It has been observed that the heart displaces superiorly and leftward with the
expanding uterus [42]. The ventricular wall undergoes eccentric hypertrophy primarily in the first
trimester and later accommodates increased end-diastolic blood volume in the second and third
trimesters [43]. The ventricular muscle has also been found to be more compliant, believed also
to support vasodilation and larger blood volume.

2.2.1 Hemodynamics of the arterial system in pregnancy
These anatomical changes to the heart allow for an increased cardiac output by 30-50%
compared to a non-pregnant woman [43]. The cardiac output increases most rapidly in the first
trimester and plateaus by the third trimester. One study found the average cardiac output to be
4.88 L/min pre-pregnancy and 7.34 L/min by delivery [44]. The cardiac output also redistributes in
pregnancy with a larger percentage of blood going to the uterus and breasts compared to prepregnancy (Fig. 5).
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Figure 5 Pre-pregnancy (A) and pregnancy (B) distribution of cardiac output to end organs
As mentioned previously, cardiac output is the product of stroke volume and heart rate. In
pregnancy, cardiac output increases because both stroke volume and heart rate increase.
Typically, the stroke volume increases rapidly in the first trimester, reaches its peak in midgestation and falls slightly by term, whereas the heart rate increases steadily until late third
trimester when it plateaus until term.
Darcy’s Law states that the product of cardiac output and systemic vascular resistance are about
equal to the difference between mean arterial pressure and right atrial pressure (or central
venous pressure). The increase in cardiac output during pregnancy is counterbalanced by a drop
in systemic vascular resistance, which reaches its lowest point mid-gestation and rises slightly by
delivery. The decrease in systemic vascular resistance causes both mean arterial pressure and
the difference between mean arterial pressure and right atrial pressure to decrease while the right
atrial pressure stays the same [43]. Decreasing systemic vascular resistance is believed to
prevent the heart from needing to work too hard to pump a larger blood volume throughout the
body. This is believed to be mediated through the nitric oxide pathway resulting in vasodilation
and increased vascular compliance [25, 43]. Fig. 6 shows the trajectory of cardiac output, mean
arterial pressure, and systemic vascular resistance during gestation [45].
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Figure 6 Time-resolved graph of cardiac output (CO), mean arterial pressure (MAP), and
systemic vascular resistance (SVR) changes throughout the course of pregnancy [45].
These hemodynamic alterations typically resolve 6 months after delivery.
Although most women are able to lie supine while pregnant without experiencing hypotensive
symptoms, up to 8% of women do experience supine hypotensive syndrome, which includes low
blood pressure and low heart rate [43]. This is explained by compression of the inferior vena cava
by the uterus, which decreases venous return, stroke volume, and cardiac output. In symptomatic
women, lateral decubitus positioning is recommended to minimize the reduction in cardiac output
[42].

2.2.2 Hemodynamics of the venous system in pregnancy
Venous blood pressure in the upper extremities does not generally change with pregnancy but
tends to rise in the lower extremities. Venous blood vessels also increase in compliance which
leads to low flow rate and stasis. These conditions explain why pregnant women are known to
develop or be at risk of developing thrombosis, edema, and varicose veins in the lower
extremities. Another area where women are at risk of developing edema is in the lungs. As the
blood volume in pregnancy increases, the colloid oncotic pressure can decrease while the
pulmonary capillary wedge pressure (estimate of left atrial pressure) can increase. When it is
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difficult for fluid to be reabsorbed or retained in the capillaries, fluid can potentially enter the
alveoli and cause pulmonary edema with signs of dyspnea and reduced exercise tolerance [25].

2.2.3 Fluid properties of blood in pregnancy
In pregnancy, the overall blood volume increases 40% [46]. The two main contributing factors
are: 1) a 20-30% increase in red blood cell mass and 2) a 45% increase in plasma volume. Red
blood cell expansion is mediated by increased production rather than the extension of cell life in
the circulation. In pregnancy there is a higher concentration of 2,3-diphosphoglycerate (2,3-BPG)
which encourages oxygen to dissociate from maternal hemoglobin and bind to fetal hemoglobin.
It has been postulated that NO-mediated vasodilation of vasculature and retention of water and
sodium cause plasma volume to increase from 3.1-4 L (middle of first trimester) to 4.7-5.2 L
(middle of third trimester). The increase in plasma volume is generally higher than the increase in
red blood cell mass so often hematocrit is lower in pregnant mothers than in non-pregnant
women.
There is a significant increase in the number of leukocytes in pregnancy with a white blood cell
3
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count of ~8000/mm in the first trimester and up to 30,000/mm during labor and delivery [51].
This is believed to result from the general stress of pregnancy rather than infection; the white
blood cell count typically resolves post-partum [51, 57]. The increase in neutrophils accounts for
most of this expansion. The number of lymphocytes first decreases from the first to second
trimester, and then increases in the third trimester. The increase in monocytes has been
interpreted as playing a role in preventing fetal allograft rejection by the maternal immune system
[57].
Pregnancy is often described as a hypercoagulable state, which is believed to protect the mother
from severe peripartum hemorrhage. However, this does put her at risk of thromboembolic
disease considering the presence of three main contributing factors: vascular damage, venous
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stasis, and a pro-coagulation circulatory milieu. The vascular damage comes from general
venodilation and venous stasis from compression of the inferior vena cava as well as major pelvic
veins [53]. Features of hypercoagulability in pregnancy include increased Protein S activity,
increased resistance to activated Protein C (despite relatively unchanged levels of Protein C),
and increased fibrinogen and other factors that promote thrombin production.
3

The platelet count decreases in pregnancy and can be as low as 70,000-150,000/mm (for
3

comparison, non-pregnant platelet count range is 150,000-400,000/mm ) probably because of
increased plasma volume and increased clearance of platelets [51, 57]. This condition is called
gestational thrombocytopenia, resolves a couple weeks after delivery, and has not been found to
have negative effects on the pregnancy [51]. It is believed that gestational thrombocytopenia is
balanced by increased platelet aggregability to prevent excessive bleeding.
The composition and transport efficiency of nutrients in the circulatory system are not only
important in pregnancy for supporting maternal health but also determine healthy fetal
development. In pregnancy, the body’s need for iron significantly increases probably because of
the demands of erythropoiesis, the process of generation of new red blood cells [47]. In fact,
normal pregnant women can become slightly anemic and are encouraged to take iron
supplements. Two other important nutrients are folate and vitamin B12, which are believed to be
important for healthy neural tube development in the fetus as well as the prevention of anemia.
In pregnancy, whole blood viscosity decreases as gestation progresses. This primarily results
from the increase in plasma volume outpacing the increase in red blood cell mass, sometimes
termed “hemodilution,” a phenomenon reflected by clinically decreased hematocrit [48]. Since
blood is a non-Newtonian, shear-thinning fluid, its viscosity is higher at low shear rates than at
high shear rates. At low shear rates, such as in small veins and in the intervillous space of the
placenta, the viscosity is high. High viscosity enhances red cell aggregation and impedes flow but
the lower hematocrit of maternal blood counterbalances this effect by lowering viscosity. In
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general, it is believed that low viscosity of blood plays a role in low resistance blood flow in
pregnancy to ensure efficient transfer of nutrients in the placenta [43].

2.3 Normal physiology of placental development, function, and remodeling
of uteroplacental circulation
2.3.1 Stages of placental development
The multi-functional nature of the placenta as the “fetal renal, respiratory, hepatic,
gastrointestinal, endocrine, and immune systems” [19] makes it a profoundly unique organ of the
human body with significant consequences of long-term health of mother and child. Figure 7
outlines the stages of placental development in each trimester, the details of which will be
explained in the ensuing paragraphs. For the purpose of understanding the stages of placental
development it is helpful to summarize the key components of a mature placenta. The placenta is
a disc-shaped organ attached to the inner uterine wall near the anterior or posterior side of the
maternal pelvis. The placenta itself is divided into the maternal side and the fetal side. On the
maternal side is the uteroplacental interface, which is also called the basal plate. At this junction
is where maternal blood enters the central cavity of the placenta, called the intervillous space
(IVS). The fetal side is also called the chorionic plate, from which the umbilical cord extends
outward and attaches to the umbilicus of the fetus. Within the chorionic surface the umbilical cord
is connected to a network of vessels arranged in a tree-like structure called villi. The terminal
branches of the fetal villi project into the intervillous space and are therefore bathed by maternal
blood. In this configuration, the fetal circulation and maternal circulation never mix but oxygen,
metabolites, and waste are transferable in a regulated manner across a thin layer of cells on the
surface of the fetal villi [49]. In this way, the placenta temporarily performs the functions of various
organs for the fetus while the fetus’s own organs are in development.
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Figure 7 Stages of placental development from first to third trimester (adapted from [42]
and [50]). In the first trimester, histiotrophic nutrition provided by endometrial glands
supports cell differentiation in the blastocyst to form the primitive structures of the
placenta. In the second trimester, the remodeled maternal spiral arteries become patent
and deliver blood to the intervillous space. Nutrients and waste pass between the maternal
blood pool in the intervillous space and the fetal circulation through the membrane of the
fetal villi. By the third trimester, the mature placenta has formed lobular structures on the
maternal surface and the umbilical cord attaches near the center of the placenta on the
fetal surface.
Placental development in the first trimester consists of a series of cellular changes that occur
during fertilization and implantation. In humans, fertilization occurs in the fallopian tubes of the
mother, after which the zygote differentiates into a blastocyst as it travels into the uterine cavity.
The blastocyst orients such that the inner cell mass and the trophectoderm are near the uterine
wall. Then, the trophectoderm is expelled from the blastocyst. The expelled trophectoderm is
called extravillous trophoblast (EVT), meaning that it will not be directly part of the placenta, but it
plays the key role of invading the inner third of the myometrium for secure anchorage of the
placenta. Furthermore, the EVTs differentiate into endovascular EVTs and interstitial EVTs. The
endovascular EVTs migrate into the lumens of the maternal spiral arteries and partially replace
the smooth muscle layer and endothelium of the terminal segments with fibrinoid tissue [42, 51].
The interstitial EVTs facilitate this process in the stroma surrounding the spiral arteries.
For the first 9 weeks or so of pregnancy (most of the first trimester), the growing placenta,
umbilical cord, and embryo are supported by histiotrophic nutrition [52]. At this stage, the
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endovascular EVTs occlude the spiral arteries while remodeling occurs such that only small
amounts of blood plasma can enter through. Nutrients from this plasma and surrounding
endometrial glands nourish the young placenta and fetus in early development. The placenta
begins to form as syncytiotrophoblast cells surround the blastocyst, lacunar spaces enlarge to
form the IVS, hemangioblasts differentiate to form the fetal villi, and part of the yolk sac becomes
umbilical cord.
By the end of the first trimester, the plugs formed by endovascular EVTs occluding the spiral
arteries disintegrate and maternal blood carrying oxygen and nutrients enter the IVS. This marks
the beginning of placental development supported by hemotrophic nutrition [52], which lasts
throughout the second and third trimesters. The quality of hemotrophic nutrition hinges on the
terminal ends of the spiral arteries to properly convert from narrow vessels (0.4-0.5 mm diameter)
into wide, trumpet-like conduits (2-3 mm diameter) opening into the IVS. Mathematical modeling
has demonstrated that there are essential hemodynamic consequences in the IVS from EVTmediated remodeling of the spiral arteries [53]. First, the wide terminal vessels help slow down
the speed of inflowing blood to prevent damage to fragile villi based on a modified version of
Poiseulle’s equation (Fig. 8a). Second, slow blood flow maintains a circulation duration of
approximately 25 seconds in the IVS to allow time for transport of oxygen and nutrients. Third,
maintaining lower pressure in the IVS compared to fetal villi ensures that the fetal villi are able to
dilate, thereby maintaining a thin barrier for oxygen and nutrients to cross (Fig. 8b). Fourth, loss
of vasoactive smooth muscle cells allows the constancy of flow to be maintained to prevent a
situation where intermittent delivery of oxygen would lead to placental oxidative stress.

21

Figure 8 Results from mathematical model of spiral artery remodeling presented in Burton
et al. [53]; a) graph showing dramatic decrease in speed of blood flow when the radius of
the spiral artery increases, b) graph showing decrease in pressure along the unremodeled
proximal end of the spiral artery until it matches the pressure of the IVS in the wide,
trumpet-like terminal end of the spiral artery after remodeling.
Although blood is able to percolate freely throughout most of the IVS, the placenta is partially
divided into 10-40 lobules by septae [42, 54]. Each lobule consists of one spiral artery ejecting
blood toward two or three fetal stem villi. The syncytiotrophoblast cells comprising the thin
membrane on the fetal villi mediate regulated transport of substances such as water,
oxygen/carbon dioxide, proteins, steroid hormones, inflammatory factors, and waste into and out
of the fetal circulation. Oxygen and other gases cross by diffusion whereas larger substances
cross by channels, transporters, vesicles, receptor-mediated processes, and other mechanisms
[42]. In fact, researchers have found evidence that the placenta is a metabolically active organ
with oxygen consumption matching that of the fetus [55]. It also has high expression of enzymes
for glucose metabolism [56].
Hemotrophic nutrition of the fetus and placenta continues in the third trimester until term. The
thickness of the placenta stops increasing at about 2.3-3 cm in the mid-second trimester but the
circumference continuously increases until term [42, 57]. The mature placenta is measured at 1520 cm in diameter [42, 57] and weighs 450-508 g. The fetal villous surface amounts to about 102

14 m in surface area available for exchange [42]. Placental biologists have observed similarities
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between third trimester placental tissue and the aging of other organs [58]. The underlying
process is called cellular senescence, when irreversible cell cycle arrest causes the cell to cease
dividing. It has many characteristic biomolecular features including unrepaired DNA damage. The
fusion of cytotrophoblasts to form multi-nuclear syncytiotrophoblasts is an important process in
pregnancy. This process begins in early pregnancy and continues as syncytiotrophoblasts at the
end of terminal villi often break off, enter maternal blood, and must be constantly regenerated
until term. Research has shown that syncytiotrophoblast cells inherently present with
characteristic features of senescent cells, such as the inability to divide and minimal DNA
synthesis. Senescent cells in the maternal stroma and fetal membranes have also been observed
to play an important role in concluding pregnancy. It is believed that one of the early processes of
labor is the release of sterile inflammatory signals from these cells. This is followed by remodeling
of the uterus and cervix to prepare for birth.

2.3.2 Anatomical and physiological remodeling of maternal pelvic
vasculature
The surrounding maternal vasculature also undergoes remodeling during placental development
as the placenta receives its blood supply from a network of vessels in the female pelvis.
Anatomically, the left and right common iliac arteries branch off of the aorta and divide into the left
and right internal and external iliac arteries. On each side, the internal iliac artery divides into
several branches providing oxygenated blood to organs and tissues in the gluteal and pelvic
region. One of these branches is the uterine artery, a tortuous vessel that eventually attaches to
the uterine wall. It is believed that the tortuosity of the uterine arteries helps accommodate
enlargement of the uterus by extending its undulations, potentially preventing rupture during
pregnancy [49] (Fig. 9a,b). There may be some natural anatomical variation in the origin of the
uterine artery in some women. The uterus is supplied by two arterial systems (uterine and ovarian
arteries) and drained by two venous plexuses (uterine and ovarian veins).
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The uterus receives oxygenated blood primarily from the uterine arteries and ovarian arteries
joined by the utero-ovarian communicating arteries. There is also a small contribution from the
blood vessels contained within the broad ligament, a sheet of tissue draped over the ovaries,
ovarian arteries, uterine arteries, and other tissues supporting the uterus [49]. Studies have
shown that occluding the internal iliac arteries lead to recruitment of collateral flow from branches
of the aorta, external iliac artery, and femoral artery [59]. The redundancy in blood supply
appears to play a protective role in maintaining blood flow to the uterus [49].
The uterine arteries ascend the two sides of the uterine wall within the broad ligament. When they
penetrate the myometrium, they divide into smaller branches called the arcuate arteries which
course in a semicircular pattern in the outer third of the myometrium. There are anastomoses that
form between the left and right arcuate arteries and between arteries and veins. The arcuate
arteries branch into the radial arteries which head towards the endometrium and terminate as
spiral arteries to supply blood flow to the endometrium [59] (Fig. 9c).

a

b

c

Figure 9 Vascular anatomy of a) non-pregnant female and b) pregnant female. Panel c
shows a cross section of the uterus showing the smaller branches of the myometrial
arteries feeding the placenta in pregnancy [49]
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As gestation progresses, it has been observed that uterine arteries carry 20-50 mL/min of blood
in the non-pregnant state but this increases up to 800 mL/min of blood in the pregnant state [60,
61]. This 10-fold increase is mediated by a decrease in uterine artery resistance since the
pressure=flow*resistance (Darcy’s Law) and pressure is generally maintained constant. Recall
4

that the Hagen-Poiseulle equation states that the resistance (R)=8µL/(πr ), where µ = fluid
viscosity, L = length of pipe, and r = radius of pipe. Although elongation of the uterine artery alone
would increase R, it is overcompensated by circumferential remodeling (increased r). As the
fourth power in the denominator indicates, an increase in the uterine artery radius contributes
significantly to the decrease in R. Specifically, this vasodilation has been described as “outward
hypertrophic” meaning an enlargement of lumen area without much wall thickening. Based on
animal studies, both smooth muscle cell hypertrophy and hyperplasia contribute to this luminal
enlargement [60, 62].
th

Interestingly, the uterine artery diameter increases weeks before the 10 week when trophoblasts
invade the spiral arteries. This appears to be anticipatory in order to provide enough influx of
th

blood flow at the start of hemotrophic nutrition around the 13 week. The blood flow increase
begins to plateau by the third trimester [57, 63], while the fetal weight begins to increase in the
second trimester with fastest growth in the late third trimester [49, 64]. Finally, there is a decrease
in uterine artery flow, which is consistent with observed increase in myogenic tone at the end of
the pregnancy to reduce hemorrhage [46, 62, 65]. The time course of all these hemodynamic
changes in the female pelvis demonstrates how the blood supply is prepared and maintained to
support the pregnancy yet without too much blood loss by term.

2.4 Pathophysiology of hypertensive pregnancy disorders
2.4.1 Historical progression in the understanding of HPD
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The current clinical understanding of hypertensive pregnancy disorders traces back to 3000 B.C.,
which is estimated to mark the earliest written reports of eclampsia from nearly every continent
[66]. Prior to the era of scientific inquiry, various theories proposed included possession by evil
spirits in biblical times and imbalance of “humours” by Hippocrates [67]. The earliest risk factor of
pregnancy-associated convulsions was primiparity reported in 1694. In the 1840s, proteinuria was
discovered as an early manifestation of eclampsia, leading to the term “preeclampsia.” At this
time, however, toxemia was believed to be the culprit, leading to the practice of blood-letting in
attempt to temper the disease. Following the invention of the blood pressure cuff in 1897,
hypertension was discovered in some pregnant women with and without edema, proteinuria, and
convulsions. In 1976, the phrase “hypertensive disorders of pregnancy” was coined to convey the
spectrum of this disease encompassing gestational hypertension, preeclampsia, eclampsia and
their subtypes [68]. Starting in the 1960s, placental examinations and placental bed biopsies
revealed evidence of shallow implantation in cases of HPD. Specifically, it appeared that the
trophoblasts failed to fully invade the spiral arteries at the inner third of the uterine myometrium,
resulting in persistence of narrow, muscular vessel walls rather than fully converting to the
necessary wide, flaccid conduits needed for adequate delivery of blood flow to the placenta and
fetus (Fig. 10).
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Figure 10 Comparison of normal and abnormal spiral artery morphology commonly
observed in preeclampsia: a) diagram of physiologic terminal spiral artery conversion to
large funnel-like vessels, b) diagram of narrow spiral arteries restricting blood flow into
the placenta, c) normal basal plate vessel from normal uterine remodeling, d) basal plate
vessel with visible thick, smooth muscle layer of vessel wall because of incompletely
remodeled spiral artery, e) basal plate vessel with acute atherosis and fibrinoid necrosis
possibly because of poor spiral artery remodeling. Panels a,b were adapted from [53] and
pathology images in panels c,d,e were provided by Rebecca Linn, MD at Children’s
Hospital of Philadelphia.
However, the view that defective trophoblast invasion of the spiral arteries was the primary cause
of HPD was later challenged with the observation that some women with preeclampsia do not
have placental disease while placental disease can be present in other women who do not have
preeclampsia yet have small-for-gestational age fetuses [69].
In the 1980s, attention began to shift toward endothelial dysfunction as the phenomenon
explaining the multi-organ involvement in HPD as more clinical features were described. These
included glomerular endotheliosis, liver disease, and eclamptic convulsions. Serological analysis
of pregnant women with and without preeclampsia showed similar biochemical profiles as those
with hemolytic uremic syndrome, pointing to possible endothelial injury activating the coagulation
cascade and a maternal circulatory environment that is hypersensitive to vasopressors [70].
Some explanations for endothelial dysfunction in pregnancy are pre-existing chronic
hypertension, type II diabetes, and generalized maternal inflammatory response [69, 71].
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2.4.2 Overview of current theories regarding placental and cardiovascular
origins of HPD
Today, HPD, particularly preeclampsia, continues to be referred to as “a disease of theories” [66].
The unifying theme in all these theories appears to be the debate over how placental disease is
connected with the maternal systemic manifestations, given that both do not always occur in
HPD-related adverse pregnancy outcomes. Roberts et al. suggest that shallow implantation of the
placenta with poorly remodeled spiral arteries leads to release of biochemical factors that injure
the endothelial cells of the rest of the circulation [70]. This appears to be consistent with
glomerular endotheliosis and other signs of organ damage. This could also explain why HPD is
cured by delivery of the placenta [67, 70]. On the other hand, Kalafat et al. argue that placental
malperfusion is secondary to cardiovascular impairment because endothelial dysfunction can
impair the response of uteroplacental arteries to vasodilators and other remodeling factors [72]
(Fig. 11).
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Figure 11 One theory proposed to explain the mechanism of preeclampsia states that
initial poor cardiac reserve makes the maternal cardiovascular system susceptible to
disease because of poor adaptation to the demanding physiological changes of pregnancy
[73]. This positive feedback loop puts mother and fetus at further risk over time. This leads
to the final common pathway of signs and symptoms commonly observed in patients
include hypertension and proteinuria.
A convincing perspective held by many today takes into account the two subtypes of
preeclampsia: early-onset preeclampsia is defined as disease detected prior to 34 weeks
gestation and late-onset preeclampsia as disease detected after 34 weeks gestation. Studies
have shown that early-onset preeclampsia is more strongly associated with fetal growth
restriction, placental lesions related to maternal underperfusion, and lower placental weight
compared to late-onset preeclampsia [74, 75]. Late-onset preeclampsia is more associated with
maternal obesity and large-for-gestational age fetuses [76, 77]. As a result, some have suggested
viewing early-onset and late-onset preeclampsia as having two separate etiologies, placental or
maternal, respectively [74].

2.4.3 Clinical perspective of hypertensive pregnancy disorders
29

2.4.3.1 Categorization of HPD
HPD is a broad term encompassing various forms of hypertension during pregnancy, including
chronic hypertension, gestational hypertension, preeclampsia, and eclampsia. Chronic
hypertension refers to preexisting hypertension prior to 20 weeks gestation while gestational
hypertension is new onset of hypertension after 20 weeks of gestation. Preeclampsia is defined
as new onset of hypertension after 20 weeks of gestation and proteinuria or, in the absence of
proteinuria, with the presence of thrombocytopenia, renal dysfunction, liver dysfunction, or
pulmonary edema [78]. Figure 12 is a diagram illustrating the various types of HPD. Preeclampsia
is the primary focus in the following sections, although there may be overlap with other forms of
HPD in terms of risk factors, screening, and treatment.

Figure 12 Types of HPD arranged by timing of occurrence during gestation, signs, and
symptoms

2.4.3.2 Risk Factors of HPD
The risk factors for HPD can generally be divided into two categories [78]. First, the majority of
the risk factors relate to maternal predisposition to develop cardiovascular disease, including
elevated body mass index (BMI), caloric excess, smoking, African American ancestry, high blood
pressure, older age, and diabetes. These characteristics warrant close monitoring during
pregnancy for development of preeclampsia. Secondly, pregnancy-specific characteristics such
as nulliparity, excessive placental size, barrier contraception, and multiple gestations are
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placental or pregnancy-specific risks of preeclampsia [12]. This framework is closely connected to
current theories about the mechanism of preeclampsia. Some argue that the mother’s
predisposition to cardiovascular disease entails subclinical endothelial dysfunction [72] that can
lead to the development of placental lesions and a deficit of angiogenesis during pregnancy.
Others identify insufficient trophoblast invasion as inciting reduced placental perfusion that affects
maternal cardiovascular health [53]. There may also be a genetic component of preeclampsia risk
that is still being investigated [79]. The connection between risk factors and the cause of
preeclampsia is still an active area of research. In this thesis specifically, MRI techniques are
developed to assess endothelial dysfunction by estimating pulse wave velocity in the maternal
arteries and to assess spiral artery function by characterizing placental perfusion distribution.

2.4.3.3 Signs and Symptoms of HPD
Patients with preeclampsia can present with concerning symptoms such as swelling, headaches,
right upper abdominal or shoulder pain, and shortness of breath [80]. Physicians typically follow
up with blood pressure monitoring and urine analysis. A systolic blood pressure of >140 mmHg
(or diastolic blood pressure of 90 mmHg) on two separate occasions at least 4 hours apart after
20 weeks gestation is cause for concern [78]. Elevated protein in the urine that meets a clinical
threshold, such as a dipstick reading of 2+, could also meet the criteria for preeclampsia [78].

2.4.3.4 Treatment Options for HPD
As a preventative measure, United States guidelines recommend prescribing low-dose aspirin (81
mg/day) to asymptomatic patients with two or more risk factors for preeclampsia [78, 81]. This
was based on clinical studies that showed that 60-150 mg/day of aspirin led to a decrease in
preeclampsia risk by 24% [81]. For preeclamptic women who have already become symptomatic
after 20 weeks, physicians have to make the complex decision of whether to induce preterm labor
to control the disease or proceed with expectant management. More advanced tests to aid in this
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decision include uric acid testing, fetal ultrasound, and fetal antepartum testing [78]. The specific
resources available at the healthcare facility for maternal and neonatal care are also taken into
consideration. A gestational hypertensive pregnancy or preeclamptic pregnancy without severe
features such as thrombocytopenia, impaired liver function, and pulmonary edema are generally
monitored until 37 weeks gestation, after which delivery is recommended. Continued observation
can involve weekly laboratory testing and serial ultrasonography. However, if the pregnancy is
complicated by severe features or dire events such as placental abruption, then induction of labor
is more heavily considered [78].

2.4.3.5 Intrapartum Care of HPD Patients
The two main goals of managing women with preeclampsia during labor and delivery aside from
routine prenatal care, are the prevention of seizures and the control of hypertension [78]. For
women with preeclampsia and severe features, it is recommended to administer magnesium
sulfate to prevent seizures. In addition, these patients should also be prescribed antihypertensive
medication—most commonly labetalol, hydralazine, or nifedipine—to prevent congestive heart
failure, myocardial ischemia, renal injury or failure, and ischemic or hemorrhagic stroke.
Antihypertensive therapy should begin immediately as soon as persistent severe hypertension
>160/110 mmHg is detected. Milder cases such as those with gestational hypertension or
preeclampsia without severe features should be monitored in case of developing severe features.
The mode of delivery should be considered on an individual basis. Induction of labor with vaginal
delivery is still possible at later gestational ages. Vaginal delivery is less safe for preeclampsia
with severe features which tend to involve low-birth-weight infants. Records show that the rate of
cesarean section is 97% at <28 weeks gestation and 65% at 28-32 weeks gestation. Epidural or
spinal anesthesia is safe for pain management as long as the patient is hematologically stable
[78].
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2.4.3.6 Postpartum Care of HPD Patients
After delivery, women with preeclampsia should be continually monitored for symptoms that can
be indicative of eclampsia, pulmonary edema, or stroke. Non-steroidal anti-inflammatory drugs
(NSAIDs) that are used for pain management can exacerbate vasoconstriction, swelling, and
sympathetic nervous system activation, although multiple studies have not shown an increase in
blood pressure with NSAID use in patients with preeclampsia [82, 83]. Women with preeclampsia
are at double the risk of CVD and five times the risk of hypertension in later years [84]. This can
probably be explained by the shared mechanism of endothelial dysfunction in both
atherosclerosis and preeclampsia [78]. It is still unclear if preeclampsia leads to cardiovascular
disease or rather that pregnancy uncovers underlying preexisting risk of cardiovascular disease
that manifests as preeclampsia. Whatever the case may be, women are advised to make lifestyle
modifications (diet, exercise, weight management) to control risk factors for cardiovascular
disease and to obtain routine primary care examinations. They should also be made aware that
they are at an increased risk of developing preeclampsia again in a future pregnancy.
There may also be life-long consequences of preeclampsia for the infant. Studies have shown
that infants born from hypertensive pregnancies have a higher risk of low birth weight compared
to normotensive pregnancies [76, 85]. The risk of perinatal mortality is also higher for
preeclamptic pregnancies compared to normotensive pregnancies with largest causes being
placental insufficiency, placental abruption, and prematurity [12]. A meta-analysis on
cardiovascular risk factors of children born from preeclampsia report that they have 0.6 kg/m
higher BMI, 2.5 mmHg higher systolic and 1.4 mmHg higher diastolic blood pressures [86].
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2.4.4 Ongoing investigations in basic science, treatment, and technological
assessment of HPD
Investigations using molecular assays [87] and animal models [88] continue to mine for the cause
of HPD. However, identifying the mechanism of this disease is not only important for driving
clinical trials exploring a wide array of pharmacological treatments [13, 89, 90], but is also critical
to improving tools used by obstetrician-gynecologists for efficiently identifying patients who are at
highest risk and would benefit from those treatments. The next section introduces the noninvasive technologies (ultrasound and magnetic resonance imaging) that were investigated in this
dissertation for potential in improving the understanding of HPD pathophysiology and clinical risk
stratification.
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CHAPTER 3: NON-INVASIVE TECHNOLOGIES TO ASSESS
CARDIOVASCULAR DISEASE
In this chapter, an overview of Doppler ultrasound, flow and perfusion magnetic resonance
imaging (MRI) is presented. These technologies have been well-explored in various
cardiovascular disease and continue to be of interest in clinical obstetrics and obstetrics research.
This summary is designed to provide the foundational physical and engineering principles of the
research presented in Chapters 4-7.

3.1 Principles of Doppler ultrasound
3.1.1 Signal generation
Ultrasonography operates based on the principle that high frequency (2-15 MHz) sound waves
travel through the human body as mechanical vibrations. These sound waves are generated by
piezoelectric crystals in the ultrasound probe, also called a transducer. The speed of sound, c,
varies based on the type of medium it travels in. It is about 1.45 mm/µs in fat, 1.58 mm/µs in
muscle, and 1.57 mm/µs in blood. The average c is said to be 1.54 mm/µs [91]. The wavelength,
l, of the sound wave travelling through tissue depends on the frequency, f, of the sound pulses
generated by the transducer according to the relationship l=c/f. The longer the wavelength, the
greater the penetration into the body but the lower the spatial resolution of the image. Conversely,
shorter wavelengths help produce high resolution images but with shallower penetration.
The energy delivered to the tissue by ultrasound imaging can be described by amplitude, power,
and intensity. Amplitude (P) is the amount of increase and decrease in mechanical vibration
pressure, described in units of Pa. Intensity (I) describes the amount of energy per unit area,
2

expressed in units of mW/cm . Power is the overall energy transfer and is measured in W. Power
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and intensity decrease as sound waves travel deeper into tissue. The amount of energy delivered
is important in obstetric US safety considerations. Some of the ultrasound energy can be
absorbed by the tissue which results in heating so the instrument display also includes a thermal
index (TI) estimating the rise in temperature based on time-averaged acoustic power/intensity,
sound beam properties, and tissue properties. Obstetric guidelines state that temperature rise of
less than 1.5 degrees Celsius is unlikely to harm the mother and fetus [92, 93]. However, pulsed
Doppler ultrasound does deposit more power than standard B-mode scanning so it is typically
reserved for second and third trimester exams (see Section 3.1.6). Another concern of ultrasound
is that high amplitude pressure waves can potentially cause cavitation, the collapse of nearby gas
bubbles, instrument manufacturers include a mechanical index (MI) to alert the sonographer to
the amount of cavitation risk. However, in obstetrics cavitation is rarely a concern because the
pregnant uterus does not contain significant gas bodies [92, 93]. The American Institute of
Ultrasound in Medicine (AIUM) recommends that sonographers use energy levels that are “as low
as reasonably achievable” (ALARA principle) to minimize risk of tissue damage [94].
US intensity decreases as the waves travel deeper into tissue. Some of the energy becomes
absorbed as previously described, and the rest can become reflected or scattered. Different
tissues have different acoustic properties, called acoustic impedances. Tissues of different
acoustic impedances positioned next to each other form an interface off of which US waves
reflect. The echo that forms at the interface is based on the acoustic impedances of the tissues.
This is quantified by the amplitude reflection coefficient R=(Z2-Z1)/(Z2+Z1), where Z1 and Z2 are
the acoustic impedances of tissues 1 and 2, respectively. A common example is the visibility of
the smooth blood vessel wall seen in US imaging because of the reflection of US waves at the
interface between the vessel wall and the blood pool separating two distinct acoustic impedances
(high R). Some tissues have rough surfaces or many small interfaces compared to the US
wavelength. These tissues tend to form scattered echoes which propagate in various different
directions with relatively homogeneous amplitude. Doppler US, a type of US which measures
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blood flow, uses the principle of scattering by transmitting and receiving waves which scatter from
the moving red blood cells. The red blood cells have scattering properties because they are very
small compared to the Doppler US wavelength [91].

3.1.2 Image formation
The level of detail visible in an image depends on the lateral resolution, axial resolution, and slice
thickness. A high frequency ultrasound probe enables high lateral resolution, which requires a
small beam in the focal region so that two reflecting objects (artery and tissue, for example)
positioned close together can be distinguished on the screen. High frequency ultrasound is also
advantageous for improving axial resolution by shortening pulse durations to distinguish between
reflectors that are placed closely along the ultrasound beam. Slice thickness, or elevational
resolution, describes how well the US instrument can focus on objects perpendicular to the
imaging plane. This is typically the worst dimension of resolution in US so it is rarely considered
when optimizing obstetric US [91].
The temporal resolution of US determines how quickly changes in moving objects of the body are
reflected in the real-time image as the sonographer moves the probe or keeps it stationary. A
single frame is composed of multiple beam lines, and each beam line is composed of an echo
transmitted and received by a columnar element of the probe. The frame rate is how quickly a
frame is formed. Since the time (T) to collect one beam line is T=2D/c, where D=maximum depth
and c=speed of sound in tissue, then the time to collect one frame (Tf) is Tf=2DN/c, where
N=number of beam lines. The maximum frame rate FRmax=1/Tf=c/(2DN). The sonographer can
usually control FRmax by changing the depth or the number of beam lines. There are typically
between 100 to 250 beam lines. The echoes from each element are stored as amplitude over
depth (time of pulse arrival). After collection, the echoes undergo a series of signal processing
steps. Most common US images are in B-mode format which encodes amplitude of the echoes in
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gray scale brightness. The signals are arranged in matrix form for display (e.g. 500x500 pixels )
[91].

3.1.3 Types of transducers
One of the ways to optimize image quality is the choice of the ultrasound transducer, of which
there are several types used clinically. The first is a linear array transducer. It contains 200 or
more separate elements arranged side-by-side. 15-20 elements are activated simultaneously to
generate an ultrasound wave and receive an echo. After a small temporal delay, the subsequent
group of elements is activated. This process is repeated from one end of the transducer to the
other. The beam lines are arranged in straight lines, and the resulting image is rectangular. The
linear array is often used for peripheral vascular applications, such as imaging vessels of the arm
or the neck.
The second type of ultrasound transducer is a curvilinear array. The shape of the curvilinear
transducer is convex at the front. The elements inside are arranged similarly to the linear array
and each group of elements is activated one at a time, extending from one end to the other. Due
to the convex shape the beam lines are arranged in a fanlike fashion and the resulting image is a
sector shape. The curvilinear array is useful for imaging deep structures such as in obstetrics
looking at the fetus and placenta in the abdominopelvic region.
The third type of ultrasound transducer is a phased array transducer. The distinguishing feature
of the phased array transducer is that it contains about 120 rectangular elements side-by-side but
all of them are activated at once. The ultrasound beam changes directionality by activating small
time delays between the elements; this allows for scanning a large field of view. The phased
array transducer is useful for imaging the heart by scanning between the ribs or looking at
vessels of the brain through the temporal bone [91].

38

In obstetrics the transabdominal probe and transvaginal probe are commonly used. The
transabdominal probe is a typical example of a curvilinear array which is favored because it has a
large penetration depth. This is enabled by a frequency range of 3-5 MHz, but the low frequency
generates low spatial resolution. However, in obese pregnant women and in general early
pregnancy, the transvaginal probe which is designed to contain a curvilinear array or phased
array is more favorable because it can image tissue closer to the surface even with lower
penetration depth using higher frequency (5-7.5 MHz) which maintains high spatial resolution [42,
95]. Even though both types of transducers can be used to image the uterine artery and spiral
artery, they have limited field of view so only 3-4 cm of the vessel is visible at a time. In fact,
sonographers often identify vessels based on the velocity waveform shape while turning on color
flow mode because vessel borders are not very clear [96].

3.1.4 Doppler ultrasound
Measurement of blood flow using Doppler US hinges on the Doppler effect, a phenomenon
describing the relationship between the change in frequency of the optical or acoustic waves
transferred from source to detector and the movement of the source or detector. The Doppler
effect was first published by Austrian mathematician and physicist Christian Doppler in 1841 [57].
When applied to blood flow, the shift in frequency (fD) between transmitted frequency (f0) and
reflected frequency (fR) is defined as fD=fR-f0=(2×f0×V×cosq)/c, where V=blood flow velocity, q=angle
between US beam in the echo direction and flow direction, and c=speed of sound in tissue [91].
While technological advancement has led to several forms of Doppler US, the primary form used
clinically is color pulsed wave Doppler in duplex imaging mode with spectral analysis.
In pulsed wave Doppler, the US probe transmits short bursts of signal into the tissue and receives
scattered and reflected echoes. The echoes are amplified, divided into two channels,
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demodulated, passed through a sample-and-hold circuit, and filtered. The two channels are
separated by a 90-degree phase shift to enable detection of flow direction toward and away from
the probe [91].
Blood flow is most easily quantified using spectral analysis. Recall that velocity is encoded by
frequency shift (fD). Practically, the received echo signal contains multiple frequencies combined
in a complex signal because the typical blood vessel has a non-uniform distribution of velocities
(e.g. laminar flow) within a cross section. This is graphically displayed with the y-axis in units of
frequency, the x-axis in units of time, and the brightness of each pixel corresponding to the
amplitude of the waves of each frequency bin.
Pulsed wave Doppler samples a volume for measurement at a certain depth of the beam, which
helps with precision to measure flow in a single vessel when there are multiple vessels in the path
of the beam. To find the location of blood flow measurement, the sonographer is typically guided
by a combination of grayscale imaging and color flow imaging (duplex imaging). Grayscale
imaging, also known as the B-mode, is conventional ultrasonography where the echoes forming
the image are based on the acoustic properties of the tissue being captured. Superimposed on
this image is a color flow Doppler image, generated by an average of the velocities measured.
The brightness of the colors corresponds to velocity with the color blue meaning away from the
probe and the color red meaning toward the probe.
A major concern with Doppler US is the potential of aliasing artifacts. Aliasing occurs when the
measured velocity exceeds the upper limit set by the instrument. This is manifested by a
wraparound of the measured velocity typically from the positive to negative polarity. Consider the
time between pulses transmitted, Td, c=speed of sound in tissue, d=depth, and the pulse
repetition frequency, PRF=1/Td=c/(2d). To mitigate aliasing, it is recommended that the operator
increase the PRF which increases the y-axis velocity range or lower the zero-velocity baseline
which increases the y-axis limit in one direction. In order to prevent aliasing by modulating the
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PRF, it must be set to at least twice the echo frequency shift (fD). This is called the Nyquist
2

criterion, which when applied to US is governed by the equation Vmax=(PRF×c)/(4×f0)=c /(8×f0×d),
where Vmax=maximum velocity measurable without aliasing, c=speed of sound in tissue,
f0=transmitted frequency, and d=depth of vessel [91].
There are two other forms of Doppler US that, though not used in this study, do have advantages
and are therefore included in many clinical instruments. Continuous wave Doppler is an operating
mode in which the transmitted ultrasound beam is a continuous wave rather than a pulsed wave.
It does not localize the measurement to a particular depth of the ultrasound beam to distinguish
between multiple vessels in its path, so it is generally used for large vessels such as the aorta.
Continuous wave Doppler is also simpler and therefore more available in inexpensive systems
[92]. Power Doppler is another operating mode which processes the Doppler signal differently
from pulsed wave Doppler by displaying the power of the Doppler signal rather than the velocity
of moving blood. This means that the power Doppler signal is related to the concentration of red
blood cells that are moving and their velocity. The advantage is that it is not susceptible to
aliasing, less dependent on the beam angle, and more sensitive to low flow. However, the main
limitation is that it does not display the direction of flow [91].

3.1.5 Echocardiography and peripheral vascular ultrasound in general
cardiovascular medicine
Ultrasound of the heart, also known as echocardiography, became clinically useful in the 1970s.
There were other procedures in place to examine the heart, but they had limitations. For example,
physical examination and electrocardiography were not found to be very specific diagnostic tools
for heart disease [97]. Also invasive cardiac catheterization, though specific, was dangerous due
to its invasiveness. Currently, examining cardiovascular structure, function, and development
involves three main modes of ultrasound. The first is M-mode, which displays a one-dimensional
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projection of tissue to track its position over time. This allows the sonographer to assess the
motion of the myocardial wall, heart valves, and aortic root. The second mode of ultrasound is
two-dimensional (2D) imaging, which provides cross-sectional views of the heart to visualize
anatomical detail. Echocardiographers developed ways to measure function based on these
views, such as calculating ejection fraction and cardiac output based on tracings of the left
ventricle in the images. The third type of ultrasound examination is Doppler ultrasound, which
allows one to measure the velocity and direction of blood flow. Specifically, color flow mapping
has been useful for assessing valvular regurgitation and intracardiac shunting. Also, using
Bernoulli’s equation, one can estimate pressure gradients across different chambers of the heart,
which is related to some cardiac diseases. Doppler ultrasound can also be used to measure the
velocity of movement of the tissue, not just blood, such as when looking for asynchrony of
myocardial contraction after a heart attack. Echocardiography is usually done transthoracically,
but sometimes it is done in transesophageally using an esophageal probe that places the
transducer closer to the heart. The basic echocardiography exam involves looking at structures of
the heart in four main locations. The first is the parasternal notch, which enables visualization of
the long axis of the left atrium, left ventricle, and aorta. A slight tilt would allow one to look at the
right atrium, tricuspid valve, right ventricle, and another slight shift would allow one to visualize
the pulmonary valve and main pulmonary artery. The probe can be rotated to show the short axis
views of some of these chambers. Second, the apical window shows the four chambers of the
heart and five chambers when adding the left ventricular outflow tract. Third, the subcostal
window is often used for patients who have lung disease or surgery, and provides a good view of
the septum, four-chamber views, and vascular connections. Fourth, the suprasternal view shows
the aorta and its branching vessels [97].
Vascular ultrasound uses ultrasound to measure the structure and function of arteries and veins.
B-mode ultrasound can image the vessel wall of large vessels. Doppler ultrasound helps identify
vessels by their characteristic velocity waveforms, and knowing the normal velocity waveform
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pattern helps detect potential disease when the waveforms look abnormal [91]. For example, in
vasculitis, B-mode ultrasound is useful for measuring the thickness of the vessel wall. The vessel
wall typically has three layers, the intima, the media, and the adventitia; in vasculitis, intimamedial thickening is considered a cardiovascular risk factor. So, the ultrasound is able to quickly
and non-invasively measure the thickness to assess cardiovascular risk in cases of vasculitis
[98]. Another example is any location in the cardiovascular system that has vessel stenosis or
occlusion. Spectral Doppler, for example, has been found to be useful for assessing and
identifying the stenosis. At the prestenotic region, a key feature is high pulsatility of the velocity
waveform. Pulsatility is essentially the amplitude of the velocity waveform. At the location of the
stenosis, there is typically high velocity and low pressure in a narrow lumen based on Bernoulli’s
equation, which explains the conversion of potential energy to kinetic energy by conservation of
energy [91]. After the stenosis, there is low flow or undetectable flow. All of these features can be
detected with spectral Doppler. Another application of vascular ultrasound is assessing
arteriovenous fistula (AVF) surgery maturation for hemodialysis patients. In this case, ultrasound
in its various modes, B-mode or Doppler, can be used to measure flow rate, diameter, and depth
of the new AVF to ensure that it has matured well enough to be a dialysis access site. Vascular
ultrasound is also useful for aortic disease patients. One example is aortic dissection repair
surgery, which can sometimes cause small leaks. In this case, contrast can be injected in
conjunction with vascular ultrasound to increase sensitivity for detecting small leaks. After organ
transplants, vascular ultrasound can be used to make sure that blood supply and drainage is
adequate to the newly placed organ [98]. Vascular ultrasound can also be used to image venous
vessels. One common form of venous disease is venous thromboembolism, in which patients
with deep vein thrombosis can be at high risk of developing pulmonary embolism. Pregnant
women are also at risk of deep vein thrombosis. A thrombus that has formed either in the arm or
the leg can break off, or embolize, and clog the arteries leading to the lungs which can be fatal. A
common diagnostic procedure is for the sonographer to apply pressure to the femoral vein using
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the probe in B-mode ultrasound and measuring the diameter of the vessel to assess its
compressibility [99]. In coronary artery disease, intravascular ultrasound has been found to be
useful for evaluating atheroscelerotic plaque development [100-102].

3.1.6 Basic ultrasound in obstetrics
The standard obstetrical ultrasound exam, according to clinical guidelines (ACR-ACOG-AIUMSRU Practice Parameter for the Performance of Obstetrical Ultrasound), is divided into the first
trimester examination and a second/third trimester examination [103].
In the first trimester, the sonographer looks for the presence of a gestational sac. It is a collection
of amniotic fluid and should contain a yolk sac and embryo. This confirms the presence of an
intrauterine pregnancy. If the embryo is present, the crown-rump length is measured using
ultrasound calipers and is used to estimate the gestational age. The cardiac motion is evaluated
using M-mode ultrasound or a 2D video clip, rather than using Doppler ultrasound, to minimize
ultrasound exposure to the growing embryo. The number of fetuses is counted; if there are twins,
amnionicity and chorionicity are determined. The fetal anatomy, if visible, is evaluated for
presence of the bladder, the umbilical cord insertion, and the extremities. To test for possible
aneuploidy in the fetus, nuchal translucency thickness is measured. Sometimes Doppler
ultrasound may be used to measure ductus venosus velocity [104]. The presence of reversal of
the A wave suggests possible cardiac compromise associated with aneuploidy. The sonographer
also looks for uterine and ovarian lesions such as fibroids, and uterine anomalies that may impact
the success of the pregnancy. To ensure fetal safety, sonographers are advised to monitor the
thermal index of the ultrasound machine, which shows how much thermal energy is absorbed by
the tissues. Since bone tends to absorb more thermal energy than soft tissue, soft tissue thermal
index is used up to 10 weeks gestation and switched to bone thermal index after 10 weeks
gestation when bone has started growing in the fetus [103, 104].
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In the second and third trimester standard ultrasound exam, the amniotic fluid volume is
measured for possible presence of oligohydramnios (low amniotic fluid), which can lead to fetal
anomalies, or polyhydramnios (too much amniotic fluid), which can lead to placental abruption
and premature birth. The placenta location is evaluated for possible placenta previa. Also, the
umbilical vessel number is counted and assessed for location of insertion both in the placenta
and the fetus. The gestational age of the fetus is best measured by crown-rump length in the first
trimester, but if the crown-rump length was not found to be accurate, the gestational age can also
be estimated by using measurements of fetal anatomy. This includes the biparietal diameter,
head circumference, femoral length, and abdominal circumference. These measurements can
also be used to estimate the fetal weight, which is important for evaluating the possibility of fetal
growth restriction. Hadlock et al have published models that translate the anatomical
measurements to fetal weight [64, 105].
In the second/third trimester, the umbilical artery pulsatility index can also be measured using
Doppler ultrasound to assess for fetal growth restriction [104]. Like in the first trimester, the
sonographer again examines uterine and ovarian anatomy to look for the progression of lesions,
such as fibroids that could impact the health of the pregnancy [103]. The sonographer also
assesses fetal anatomy, particularly the brain and the heart. In the brain, middle cerebral artery
velocity is measured by Doppler ultrasound to assess for possible fetal anemia [104]. The
cerebroplacental ratio is calculated by the middle cerebral artery pulsatility index divided by the
umbilical vein pulsatility index. If the cerebroplacental ratio is too low, this is a sign of brain
sparing from physiological distress. Cardiac function is assessed by measuring umbilical vein
pulsatility for possible high pressure in the right ventricle in the fetus. Another sign of cardiac
compromise is reversal of the A wave in the ductus venosus velocity waveform measured by
Doppler ultrasound. The sonographer examines the head, face, neck, stomach, bladder, umbilical
cord insertion, spine, extremities, and sex of the fetus during the second and third trimester [103].
Sometimes the uterine artery is measured with Doppler ultrasound to assess risk for
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preeclampsia and fetal growth restriction. Uterine artery assessment will be discussed in
Chapters 5 and 6 in more detail. In many clinics, Doppler ultrasound of uteroplacental and
fetoplacental vessels are reserved for research but are mentioned here to demonstrate how they
can enhance the standard obstetrical exam.

3.2 Principles of flow and perfusion MRI
3.2.1 Signal generation
Magnetic resonance imaging (MRI) is the primary modality explored in this dissertation. MRI is
advantageous over ultrasound for patient imaging in that it has high spatial and temporal
resolution with large spatial coverage and can generate versatile contrasts to visualize different
tissues. It is less operator-dependent than ultrasound because the patient can be consistently
positioned on the table, in contrast to ultrasound’s variability due to the sonographer’s probe
orientation. The MRI signal is generated by manipulating the water protons in tissues using
magnetic and radiofrequency fields. When outside of a magnetic field water protons are oriented
randomly, but once they are put within a magnetic field they align parallel to that magnetic field
where half of the protons are pointing in the same direction and half are pointing in the opposite
direction. However, slightly more protons align with the main magnetic field (B0). At the same
time, the protons are spinning on their own axes while precessing around the magnetic field
direction at a precession Larmor frequency w=gB, where g is the gyromagnetic ratio (42.58
MHz/T) and B is the magnetic field strength (e.g. 1.5T). The collection of protons is called the net
magnetization vector. By convention, the MRI coordinate system refers to the net magnetization
vector as pointing in the positive direction of the z axis (direction of B0) at equilibrium. The B0 field
is generated by running a current through a large spiral of wire, which generates a magnetic field
based on Maxwell’s Law.
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To generate a signal, a radiofrequency (RF) pulse matching the Larmor frequency rotates the net
magnetization vector towards the x-y plane. After the RF energy is turned off, the net
magnetization begins to relax back to its equilibrium state in two independent but simultaneous
processes. Longitudinal relaxation occurs when the net magnetization vector returns to positive z
orientation. Transverse relaxation occurs when the protons begin to dephase or spread out until
the net transverse magnetization vector eventually cancels out to zero. Imaging contrast in MRI is
based on tissue-specific properties that describe how the protons interact in the presence of
perturbations in the magnetic field. T1 describes how quickly the net magnetization reaches
equilibrium parallel to B0 (longitudinal magnetization). T2 describes how quickly the net
magnetization decays along the axis parallel to B1 (transverse magnetization). T1 and T2 are
completely independent of one another but T1 ³ T2. The RF pulse can be designed to rotate the
net magnetization vector at any angle away from +z. The maximum signal is obtained with a 90º
pulse which flips the vector to the x-y plane. The magnetic flux of the excited protons induces a
current called a free induction decay (FID) into a receive coil based on Faraday's law. The signal
has real and imaginary components and is amplified, digitized, and processed.

3.2.2 Spatial encoding and image formation
Spatial encoding is required to distinguish between the different tissue regions of the patient. This
is enabled by gradient coils which form magnetic field gradients in the scanner. In order to select
a slice and control its thickness a gradient magnetic field is applied in the z direction during the
excitation RF pulse. The gradient amplitude and duration as well as RF properties such as
bandwidth, can be used to adjust the slice thickness and position. In the x-y plane, the x gradient
and y gradient cause the protons in the patient to have varying frequencies and phase. The signal
of each location is denoted by the equation ! "# , "% =

' (, ) * +,-

./ #0.1 %

2(2) , where ! is the

signal and ! is the object. Since the signal from each location is denoted by a particular
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frequency and phase offset, the coordinates of the grid are marked by spatial frequency as
1/distance. This coordinate system is called k-space. To reconstruct the image back into object
space, there are various ways to sample k-space with a Cartesian grid being one of the most
common. The spatial resolution is determined by the extent of the grid denoted by !#$"
and !#$%
" .
"

The field of view is determined by the interval between the samples denoted by ∆"# and ∆"# . The

MRI scanner is often known as a Fourier transform mechanism by encoding the signal in k-space.
Therefore, reconstructing the image of the object from k-space requires the inverse Fourier
transform. An important consideration when sampling in k-space is the satisfying the Nyquist
sampling criterion. The readout gradient has a particular sampling frequency that must be at least
two times the maximum spatial frequency in order to avoid aliasing artifacts.

3.2.3 Flow and perfusion MRI
The three cardiovascular MRI techniques discussed in this dissertation are arterial spin labeling
(Chapter 4), 2D phase contrast/4D flow (Chapters 5 and 6), and time-of-flight angiography
(Chapter 7).

3.2.3.1 Arterial spin labeling (ASL) MRI
Perfusion is the rate of blood flow into a tissue. In MRI intravenous gadolinium contrast is often
used as an exogenous tracer to estimate blood flow into organs such as the brain. However,
there are potential risks to administering gadolinium in pregnancy. Arterial spin labeling (ASL)
MRI has been a technique of interest for imaging perfusion in pregnancy because it does not
require exogenous contrast. Instead, blood water is used as an endogenous tracer by applying
RF pulses to invert the net magnetization of blood before it travels through the arteries to the
organ. Since the magnetization relaxes after the RF pulse, the perfusion-related signal decays
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according to the T1 of blood, which is about 1-2 seconds. The amount of signal also depends on
the volume of blood that is labeled using the RF pulses.
The basic framework of ASL involves the acquisition of two types of images. The label image is
created when blood is inverted and after a duration of time (post-label delay) while blood enters
the tissue, a readout module collects an image of the perfused organ. The control image is
created without any RF inversion but the same readout module collects an image of the organ.
The perfusion-weighted image is generated by subtraction of the label and control images.
Theoretically, the difference between the two images is the labeled blood which reflects
perfusion. However, in general the control-label difference is about 1% of the control image signal
so a series of alternating label and control images are acquired and averaged to enhance the
signal-to-noise ratio.
There are several types of labeling in ASL, but the one used in this dissertation is called pulsed
arterial spin labeling (PASL). The key feature of PASL is that a single RF inversion pulse is
applied to a large region of blood when acquiring the label image. Flow-sensitive Alternating
Inversion Recovery (FAIR) ASL is a specific type of PASL in which a non-selective inversion
pulse inverts all of the signal in the entire region covered by the RF coil to generate the control
image, while the inversion pulse is only applied to the imaging slab to generate label image [106].
The disadvantage of FAIR is that different spins have different transit times reducing the precision
of perfusion measurement. It is also difficult to localize where the blood is coming from. However,
FAIR ASL is relatively easy to implement compared to other labeling techniques. In the placenta
specifically, the non-selective inversion of FAIR ASL is able to tag both the ovarian arterial supply
and the uterine arterial supply (Fig. 13).
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Figure 13 This diagram shows how FAIR ASL can be applied to the placenta. The green
box shows the imaging slab and the entire blue translucent overlay shows the extent of
the non-selective inversion pulse. The placenta has a dual arterial blood supply, ovarian
and uterine arteries, which are covered by the non-selective inversion pulse.
The actual perfusion quantification (mL/min/100 g of tissue) uses a mathematically-derived model
such as discussed in Buxton, et. al. [107]. The equation takes into account post-label delay, T1,
tissue blood-water partition coefficient, and other effects. A common challenge in ASL MRI is
unwanted signal from stationary tissue causing errors in perfusion estimation. To address this
issue, background suppression is applied before labelling to reduce signal from stationary tissue.
Background suppression uses inversion pulses at specific times for the purpose of inverting and
allowing stationary tissue to become nulled or appearing as zero so as to not contribute to the
perfusion-weighted image.
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3.2.3.2 2D phase contrast (PC) and 4D flow MRI
Phase contrast (PC) MRI measures signal phase to distinguish static from moving spins. The
main feature of the PC MRI pulse sequence is the addition of bipolar velocity-encoding gradients
positioned along the direction of the blood vessel. Mathematically, the phase produced by a
gradient is defined as ! " = $

'
%
(

& ) & *&, where ! = 42.58 )*+/- is the gyromagnetic ratio

(constant), ! = duration of gradient, !(#) = gradient amplitude, and !(#) = position of the spin
[108]. This equation can be rewritten using the Taylor expansion to get
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representing !(#) in terms of initial position !" , velocity !" , acceleration !" , etc., !" becomes the
nth gradient moment with respect to these nth order terms [108].

a

b

Figure 14 Modeling of a) bipolar gradients with only m0 nulling but m1 phase
accumulation, b) velocity compensation gradients with both m0 and m1 nulling
Figure 14a (top) is a demonstration of the bipolar gradients. From ! = 0 to 1.4 ms is a pair of
identical gradients with opposite polarity. When the spins are not moving, !" , $" , and other higher
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order terms are 0. Figure 14a (bottom) shows that the zeroth moment !" increases and
decreases linearly as the bipolar gradients are played. This is because the !" is the area of the
gradient and the bipolar gradient areas cancel each other. This demonstrates that regardless of
whether the spins are stationary or moving, they experience a linear phase accumulation until ! =
0.65 ms and complete reverse their phase from ! = 0.65 to 1.4 ms because ! " = %&' " (' and

!" # = 0 at the end of the bipolar gradients.

However, the bipolar gradients are not able to recover their first moment !" , which is the area of
the gradient multiplied by the time duration that the gradient is turned on, i.e. !" = !$ * ".
Assuming that the spins are moving at a constant velocity so that !" and other higher order terms
are 0, from Eq. 2 we see that !(#) = '() (#)*+, where this time !" # ≠ 0. If the spins are
moving, the bipolar gradients are unable to refocus the spins back into phase, resulting in a
residual phase accumulation at the time of the echo. Physically, this can be explained by the
moving spins experiencing a progressively higher gradient field strength as they travel through
the pipe. This prevents the second gradient from fully recovering the dephasing from the first
gradient [108]. PC MRI is not only able to detect moving spins apart from static spins based on
the presence of phase accumulation at the end of the bipolar gradients, it is able to use the phase
measurement itself to solve for velocity which will be discussed later.
Phase accumulation leads to signal loss in the magnitude image because intravoxel spin
dephasing reduces transverse magnetization faster than surrounding static spins. In the phase
image, the velocity-dependent phase accumulation leads to misregistration artifacts in the phase
encoding direction of the image. If phase accumulation due to flow is undesired, as is the case
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when displaying vascular anatomy in angiograms, velocity compensation is necessary [108]. This
requires modifying the bipolar gradients to ensure that !" # = !% # = 0. A tri-lobed gradient is
typically implemented with some amplitude G from ! =0 to 0.8 s, -2G from t=0.8 s to t=1.7 s and G
from t=1.7 s to 2.3 s (Fig. 14b). This ensures that there is zero phase accumulation in the moving
spins as well as the static spins.
In 2D PC MRI, a pair of bipolar gradients is played along with velocity compensation gradients in
the slice select gradient direction (z). While the bipolar flow encoding gradients cause the signal
of the moving spins to accumulate phase, so do the other gradients involved in the sequence
including the slice select (z direction), phase encoding (y direction), and readout (x direction)
gradients. For this reason, the velocity compensation gradients are necessary to null the phase
effects of the other non-flow encoding gradients.
There are additional factors that give rise to signal phase errors, such as those from eddy
currents and magnetic field inhomogeneities [108]. By acquiring two consecutive scans while
toggling the bipolar gradients, i.e. positive followed by negative gradient in the first scan and
negative followed by positive gradient in the second scan, the phase images can be subtracted to
eliminate these phase errors which are relatively constant compared to phase changes from
moving spins. The phase difference is ∆" = $∆%& ', where ∆"# = 2"# which is determined from
the bipolar gradient design. The factor of 2 shows that subtracting phase images of opposite
polarity also increases the dynamic range of the phases which eases the separation of velocities.
A major consideration in deriving velocity from phase measurements is the avoidance of aliasing.
This arises from the limited range in which phase can be measured, i.e. from –π to π. In the
event that the velocity of a particular region in the image exceeds the value corresponding to φ =
π, then the phase will wrap to the negative range. To mitigate this problem, one can tune the
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definition of φ = π appropriately for the expected range of velocities to be measured in the image.
This parameter is known as the VENC (velocity encoding) and is often measured in cm/sec.
Since !"#$ =

'
(∆*+

=

'
(,-.

[109], this adjusts the strength of the gradient (G) and duration of the

gradient (τ). In practice, if one is trying to minimize scan time, the G is maximized before
lengthening τ. Although it is often desirable to set the VENC high to ensure the ability to capture a
wide range of velocities, increasing the VENC simultaneously decreases the phase signal-tonoise ratio (SNR). SNR of the phase is simply the SNR of the magnitude image weighted by the
phase φ.
Flow measured in volume/time (usually mL/min) is calculated as ! = 60%&, where A = cross
2

sectional area (cm ), v = velocity (usually cm/s), and 60 converts seconds to minutes. This means
the measurement of velocity by PC MRI combined with the knowledge of the vessel geometry
allows the computation of volumetric flow rate. Since the bipolar gradients are implemented on
the slice selection axis in the direction of flow, the slice being imaged is a circular cross-sectional
plane through the vessel. Ideally, the plane should be oriented perpendicular to the direction of
flow but if not, the velocity is !"#$(&), where ! is the orientation of the slice. The thickness of the
slice also determines the sensitivity of the velocity approximation to the orientation of the slice.
The inverse Fourier transform of the k-space data collected are complex numbers, so to extract
the phase term, one computes the arctangent of the ratio between the imaginary and the real part
of each voxel ! ", $ : ! ", $ = arctan

+, + -,.
/0 + -,.

. Phase difference reconstruction is often

described as computing ∆" by subtracting two phase images, but rather than taking the
difference of two arctangents, it is more computationally efficient to do this by taking the complex
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ratio so the arctangent only needs to be computed once: ∆" = $ = '( ') = arctan
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the phase difference image ∆" has been computed, one can extract velocity using the equation
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&'() ∶ -&'() < ! < &'() and the sign of the phase difference reflects the direction of

blood flow. Similar to the concept of the wheels of the car appearing to move backwards in a
motion picture, the flow appears to be moving in the wrong direction when

1<

#
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< 2, 3 <
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< 4, … . This is called aliasing, which can be avoided by setting a high

VENC or retrospective correction.
Unlike 2D PC MRI, which has one pair of bipolar gradients in the slice-select direction, 4D flow
MRI has bipolar gradients in all three gradient directions. There are several ways to encode flow
in all three directions. If one were to derive phase contrast imaging as described thus far and
extrapolate to encode velocity in three dimensions, six scans would be expected in order to
perform three phase image subtractions. This is called the “six-point” method. However, one can
obtain a three-component velocity vector with only four scans: reference, bipolar in x and y,
bipolar in x and z, and bipolar in y and z [110]. This is more commonly used to save scan time.
While it can be a challenge to parse the complex data from 4D PC MRI, having 3D spatial
information, 3D velocity information, and time can be powerful tools for understanding
cardiovascular structure and function. The most common approach is to display the three
dimensions of flow as velocity vectors with the color or length representing the magnitude. One
can also display flow in 3D by tracking each vector as a particle in the form of streamlines. These
streamlines have been used to demonstrate qualitative flow patterns such as whether the flow is
linear or tortuous.
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3.2.3.3 Flow enhancement in time-of-flight (TOF) angiography
To explain TOF MRI blood vessels are treated as a continuous flow of spins at constant velocity
through a cylindrical pipe. Assume that a 90-degree pulse is applied followed by a 180-degree
pulse that rephases the spins in the transverse plane. If the spins are not moving, they will be
able to experience both the 90-degree pulse and the 180-degree pulse so the signal remains
high. On the other hand, if the spins are actively flowing through the pipe, they experience the 90degree pulse but subsequently flow out of the plane of the slab such that they do not experience
the 180-degree rephasing pulse. This results in signal loss in the 2D image and appears as a
dark spot in the vessel called a flow void. Note that this is a misnomer because it implies the
absence of flow when in fact it is the presence of flow itself that causes loss of signal [109].
To correct for the flow voids, one can apply a pulse sequence with a train of repeated RF pulses
within the slice. The time between each RF pulse is the repetition time (TR). This process
repeatedly flips the static spins into the transverse plane before they get a chance to fully recover
their longitudinal magnetization signal. In contrast, moving spins upstream have not experienced
as many RF pulses, if any, by the time they flow into the slab. Therefore, their signal is higher
than that of the surrounding static tissue. If the spins are flowing fast with v*TR > h, where v is the
velocity of the spins and h is the thickness of the slab, then a volume of blood from upstream to
the slab will completely replace the slice being imaged, maximizing the intensity because these
spins have not experienced any RF pulses. However, if the spins move slowly such that v*TR <
h, then the upstream blood only partially fills the imaged slice, producing some enhancement but
not as high as the fast moving blood. The amount of signal measured also depends on the flip
angle of the RF pulse. A 90-degree pulse would immediately saturate all the spins in the first
application, but smaller flip angles take more repeats to steady state saturation, making them
more sensitive to the varied velocity of moving spins. This phenomenon is known as inflow
enhancement used in TOF MRI of blood vessels [109].
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3.2.4 Flow and perfusion MRI in general cardiovascular medicine
ASL MRI has been primarily used to study the brain for clinical medicine and research [111]. It
has been used to assess acute stroke [112], tumor vascularization [113], and dementia [114].
These conditions have been found to be closely related to perfusion, also known as cerebral
blood flow (CBF). ASL has also been used to research human behavior, learning [115], and mood
[116], as CBF plays an important role in neural activity. By understanding normal CBF patterns,
ASL has also been used to study drug effects on the brain by monitoring comparative CBF
changes. 2D PC MRI is a common technique to measure blood flow in any major vessel [117].
Velocimetry of the aorta, superior/inferior vena cava, pulmonary arteries, and other important
vessels is useful for measuring function of the cardiovascular system. 2D PC MRI can identify
stenosis, characterized by a narrow lumen with abnormally high velocity, or dissection, showing
flow in a vessel adjacent to an extra cavity. 4D flow MRI is still mostly used in research settings,
evaluating complex flow patterns in disease and post-surgical cases. One example is measuring
wall shear stress to monitor progression of atherosclerosis [22]. TOF MRI is used routinely in the
clinic to visualize vessel structure of arteries and/or veins for direct assessment or as a scout
image for other MRI sequences.

3.2.5 Flow and perfusion MRI in obstetrics
Unlike routine ultrasound screening of pregnancies, MRI is generally reserved for advanced
evaluation of high-risk cases in the event of suspected pregnancy complications. The soft tissue
contrast, large field of view, and multiplanar capabilities make MRI suitable for assessing
placental abnormalities (placental abruption, placental adhesive disorders, etc.), fetal
abnormalities, and even maternal conditions unrelated to pregnancy such as tumors [118]. While
the MRI protocols vary depending on the conditions being evaluated, localizers, T1/T2-weighted
images, and fat-suppressed images are commonly used to visualize anatomy. Advanced MRI
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techniques such flow and perfusion used in clinical obstetrics are beyond the scope of this
dissertation, but some preceding uteroplacental flow and perfusion research is briefly discussed.
One of the earliest ASL studies on the human placenta was conducted at 0.5T using FAIR ASL
which measured an average perfusion rate of 176+/-24 mL/100 mg/min. A later study of FAIR
ASL on second trimester pregnancies with small for gestational age (SGA) or appropriate
gestational age (AGA) outcomes show that SGA subjects had lower perfusion than AGA subjects
[119]. ASL MRI has also been used to study placental perfusion in mice [120, 121] and nonhuman primates [122]. More recently, innovations in labelling of ASL sequences have been
applied to the placenta as well using 3T, such as velocity selective ASL in the PERFOX technique
[123] and pseudocontinuous ASL [24].
2D PC MRI has been used to measure uterine artery blood flow in human pregnancy at 1.5T [21]
and 3T [124]. It can also be used to measure blood flow in umbilical and fetal vessels. Even
though 2D PC MRI is a widely available technique, it is challenging to orient the imaging plane
directly perpendicular to the vessel for accurate measurement of velocity within the complex
vascular network of the female pelvis. 4D flow MRI has the advantage of allowing retrospective
velocity measurement despite a long acquisition time. Recently, it has been used to study
uteroplacental vessels in non-human primates [125].
A major concern of MRI in pregnancy is safety. In the general population, the main potential
safety hazards of MRI are
1. The main magnetic field can attract metal objects, which can turn into projectiles and
place the patient and other personnel at risk.
2. The RF excitation energy can cause heating of tissue.
3. Rapid switching of gradients can cause central and peripheral nerve stimulation.
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4. The acoustic noise of the MRI can carry the risk of hearing loss.
Therefore, there has been significant research effort investigating the extent to which pregnant
women and developing fetuses may be more vulnerable to these hazards than the typical patient
previously considered. The main magnetic field was initially thought to be teratogenic or cause
fetal harm but a retrospective study did not find strong evidence of increased adverse fetal health
outcomes in those who were exposed to MRI in utero [126]. The RF energy used to excite MRI
signals does carry a risk of heating maternal and fetal tissue. The distribution of heat in the body
varies according to fetal position, maternal position, and body size and shape. To be
conservative, most MRI protocols use a 2 W/kg specific absorption rate (SAR) limit or a
temperature increase of 0.5ºC over a duration of 30 minutes [127]. The rapid switching of
gradients potentially increasing the risk of central and peripheral nerve stimulation is taken into
consideration when scanning any patient, but pregnancy has not been known to carry additional
stimulation risk beyond a general subject. The MRI scanner generates loud noises which can
cause hearing loss in the mother or fetus. The mother is required to wear ear protection. Fetal
hearing is protected by surrounding maternal tissue which can attenuate sound. Typically
scanning does not exceed the 90 dB limit set by American Academy of Pediatrics [126]. Like
ultrasound, MRI does not generate ionizing radiation and can be a powerful diagnostic tool when
the benefits outweigh the risks to the pregnant patient.
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CHAPTER 4: SPIRAL ARTERY FUNCTION BY ARTERIAL SPIN
LABELING (ASL) MRI
4.1 Abstract
Placental insufficiency has long been known to play a role in the development of HPD but the
exact physiological nature of spiral artery dysfunction is an area of active research. In this study,
Flow-sensitive Alternating Inversion Recovery (FAIR) ASL MRI was adopted and tested on
human pregnancy subjects in the second and third trimester to optimize the technique and
explore signal processing strategies that would benefit clinical understanding of HPD. 19 subjects
in the second and third trimester were imaged with FAIR ASL MRI at 1.5 T and measured
placental perfusion was 36.6, 76.4, and 118.9 mL/100g/min using manual, suprathreshold, and
Bonferroni-corrected ROIs. An alternative pattern analysis approach was tested on a subset of six
subjects. This showed that by taking a Bayesian approach with an alternate coordinate
transformation and thresholding of the blood flow clusters, gestational hypertensive subjects
seemed to have larger variation in total area and percent area than normotensive subjects. This
may result from more motion or more intermittent flow in the abnormal pregnancies. The evidence
provided by this study may serve as a foundation for future investigation in developing ASL MRI
to evaluate the perfusion dynamics of the placenta.

4.2 Introduction
Placental histopathology suggest that insufficient placental perfusion may be strongly associated
with HPD based on placental histopathology [128] because HPD often manifests as maternal
stromal-vascular lesions such as accelerated villous maturation and intervillous fibrin deposition
resulting from abnormal spiral artery flow in maternal vascular malperfusion. While the underlying
etiology of this pathology is still being investigated, researchers speculate a combination of
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genetic, environmental, and cellular processes (e.g. insufficient trophoblast invasion of the spiral
arteries) contribute to maternal vascular malperfusion [13, 128]. In addition, data-driven
mathematical modeling of blood flow in the spiral arteries and intervillous space have described
damaging high-pressure, turbulent blood flow jets and high wall shear stress entering the
intervillous space from poorly-modeled spiral arteries [53, 129]. These physiological studies
highlight the potential of in vivo hemodynamic assessment of placental function to improve
researchers’ understanding of disease progression in HPD.
Measuring spiral artery flow in human pregnancy has been challenging. Recent studies have
reported initial feasibility by Doppler ultrasound [130, 131], but they acknowledge that this is a
localized measurement so the sensitivity is too low to predict HPD. Therefore, the primary method
of measuring uteroplacental blood flow remains uterine artery Doppler ultrasound as a surrogate
for spiral artery function. Arterial spin labeling (ASL) MRI is a promising technique for measuring
placental blood flow in pregnant women because it is non-invasive, quantitative (mL/min/g tissue),
and does not require a contrast agent. While clinical MRI does not have the spatial resolution to
image individual spiral arteries, it has the potential to supersede ultrasound by imaging perfusion
dynamics and other functional aspects as such diffusion and oxygenation of the whole placenta.
Prior ASL MRI research in humans have used Flow-sensitive Alternating Inversion Recovery
(FAIR) without background suppression at 0.5T [23], at 1.5T [119], pseudocontinuous labeling
(pCASL) at 3T [24], or acquired simultaneously with oximetry [123].
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Figure 15 Diagram of placental anatomy showing blood sources and destinations around
the intervillous space, an open pool of blood [11].
However, there are significant challenges to placental ASL, including: 1) vulnerability to motion
artifacts and 2) lack of an appropriate perfusion model specific to the placenta. Motion can come
from maternal breathing, fetal motion, and uterine contractions. In addition, prior studies rely on
mathematical models of perfusion that were originally developed for organs with arterial-capillaryvenous circulations such as the brain and kidney. In contrast, the placenta is unique anatomically
and physiologically in that it consists of arterial blood flowing into an open space called the
intervillous space that can be as large as 3 cm in diameter. The blood bathes the fetal capillaries
before returning through the venous system (Fig. 15). This has led to innovations accommodating
this unique physiology. For example, it is believed that measuring blood movement in a variety of
directions, rather than in a single direction as in a capillary bed, is a critical part of the placental
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blood flow pattern [132]. These challenges were also addressed in the following ASL MRI
feasibility and pattern analysis studies I conducted.
First, feasibility of FAIR ASL at 1.5T was tested in pregnant human subjects, using background
suppression to reduce physiological noise. The advantage of FAIR ASL is that it is relatively easy
to acquire images from complex anatomy such as the placenta and surrounding vessels. 1.5T
MRI systems are more widely available and more commonly approved for imaging pregnant
women than 3T MRI, despite having considerably lower sensitivity for detecting ASL effects. This
study was presented as an abstract at ISMRM 2018 [133].
Second, an image processing approach of placental ASL images was developed to characterize
placental blood flow distribution without assuming the traditional perfusion model. Instead, the
control and label signals were considered as separate normal distributions with the same
standard deviation as a measure of temporal signal dynamics during the time of image
acquisition. An alternate coordinate space was developed with meaningful spatial descriptors that
would improve characterization of blood flow distribution from the maternal to fetal side of the
placenta. This study was presented as an abstract at ISMRM 2019 [134].

4.3 Methods
4.3.1 Feasibility of 1.5T FAIR ASL MRI in human pregnancy to measure
placental perfusion
19 healthy singleton pregnancies (GA range=17-38 weeks) were imaged to characterize normal
placental perfusion at 1.5T. HASTE localizer images were acquired in four axial slice positions
through the placenta, followed by free-breathing FAIR ASL in the same region with a 2D EPI
3

readout (4 slices, 12.5 mm gap, GRAPPA rate=2, matrix=64x64, target voxel size=4x4x10 mm ).
A background suppression (BS) scheme was optimized to suppress the static tissue signal with
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T1s between 650 and 4000 ms to 10% of its equilibrium value. An M0 scan with no magnetization
preparation and identical imaging parameters was also acquired for quantification. BS FAIR ASL
was acquired with several inversion times and test-retest reliability was also assessed in a subset
of 8 subjects.
Data analysis included motion correction of the ASL images using a nonlinear deformation [135]
and compared signal changes in three types of ROI:
1. manual tracing of the placenta based on the M0 image
2. statistical parametric mapping based on temporal correlation with the label/control
paradigm thresholded at p<0.05 (uncorrected)
3. statistical parametric mapping based on temporal correlation with the label/control
paradigm thresholded at p<0.05 (Bonferroni corrected for the number of placental voxels)
Placental blood flow was estimated using the traditional Buxton, et al. equation
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[107] with adjustment of M0 for 90% background suppression and using 1.53s

for blood T1 at 1.5T in women [136].

4.3.2 Pattern analysis of placental blood flow distribution in ASL MRI of
human pregnancy
A method of quantifying uteroplacental blood flow distribution using 2D FAIR ASL MRI was
developed and tested in 6 of the 19 singleton pregnant subjects with clinical outcomes listed in
Table 1. Rather than define a perfusion model as in traditional approaches of analyzing ASL
images, it was assumed that the label and control signals were normally distributed with the same
standard deviation. This would enable visualization of the temporal dynamics of the acquired data
in a model-free fashion. Then, a Bayesian approach was adopted by drawing 100 samples from
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the posterior distribution of the control and label signal difference. The median value from each
voxel was extracted and masked based on a statistical threshold to remove inconsistent signals.
Figure 16 demonstrates this concept in a representative image showing motion artifacts in the
control-label difference from maternal breathing, fetal motion, and uterine contractions (panels ac) with improvement in image quality in the median image (panel d) after removing motion
artifacts.

Table 1 Six pregnant subjects (subset of 19 total) whose data was analyzed using the
model-free approach to characterize placental blood flow pattern

Figure 16 Corresponding HASTE (a) and control-label difference (ΔM) images (b,c,d) at a
representative slice position in Subject C: both absolute value |ΔM| (b) and positive ΔM (c)
images show noise-like artifactual signal (blue arrows) outside of expected areas of
perfusion in the placenta and major maternal arteries. The masked median extracted from
100 samples of the posterior distribution appears to effectively remove artifacts (d).
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The advantage of acquiring axial images of the placenta is that this orientation allows for a crosssectional visualization of arterial blood flow from the maternal to fetal side. To facilitate this
analysis, an alternate coordinate system was developed by positioning a spline-based curve
along the uteroplacental interface of the placenta and projecting bidirectional rays along this
curve. Interpolation was performed along these rays to form a projected image of the ΔM signal in
both the individual 100 samples per slice and the corresponding masked median drawn from
those samples (Fig. 17b,d).
Since the blood flow signal was distributed in the form of clusters, reminiscent of placental
lobules, watershed segmentation was performed and computed various metrics on the clusters to
quantify their lobule-like pattern (Fig. 17c). A probability map was generated from the 100
samples that depicted uncertainty based on temporal signal stability within each voxel (Fig. 17e)
and the distribution of the cluster metrics was reported (Table 2). In the cohort of six subjects, the
cluster metrics on a per subject basis were generated and compared.

a

Figure 17 a) Diagram of control points and spline interpolation on a median image with
corresponding HASTE image of placenta, b) projection image from masked median image,
c) binary watershed threshold segmentation of (b), d) one of the 100 samples of the
posterior distribution, e) probability cluster map from 100 samples
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Table 2 Cluster metrics computed from the binary projection images (VU=voxel units,
AU=arbitrary units)

4.4 Results
4.4.1 Feasibility of 1.5T FAIR ASL MRI in human pregnancy to measure
placental perfusion
Using data from the p<0.05 corrected voxels, ASL signal changes starting at TI=1000 increased
with TI in a manner consistent with the increasing signal regime [107] based on an estimated
arterial transit time of 700 msec [24] (Fig. 18a). Compared to the other ROIs, the Bonferronicorrected ROI produced a larger signal (Fig. 18b). When comparing the agreement between two
repetitions of the 2000 ms inferior labeling using a more generous P<0.05 uncorrected mask, a
considerable but not perfect overlap was found (Fig. 19). Average overlap was 54% and 50% for
the p<0.05 corrected and uncorrected maps after excluding two subjects with very poor
reproducibility. Estimated placental perfusion results using the three ROI are presented in Table
3.
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Figure 18 a) Normalized ΔM% versus TI for inferior labeling with the ROI generated from
the Bonferroni-corrected threshold set at p<0.05. The predicted signal was based on
transit delay Δt=700 ms. It shows that the signal behavior across TIs matches the theory
presented in Buxton et al. [107]; b) Comparison of the normalized ΔM% versus TI curves
from the hand-drawn ROI, suprathreshold ROI, and the Bonferroni-corrected ROI. It shows
that the Bonferroni-corrected ROI produces the largest signal.

Figure 19 M0 images of posterior placenta (top row) and anterior placenta (bottom row)
with ASL ROIs generated using statistical parametric mapping of the ASL time series with
the label/control paradigm thresholded at Bonferroni corrected p<0.05 (right) and p<0.05
uncorrected (left). Test-retest maps are shown in red and blue, while overlapping voxels
are shown in green.
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TI = 2000 ms

PBF (mL/100g/min)

Manual ROI

36.62 ± 18.47

Suprathreshold ROI

76.41 ± 25.32

Bonferroni-corrected ROI

118.93 ± 34.71

Table 3 Comparison of PBF (mL/100 g/min) in three types of ROIs TI=2000ms excluding
two subjects with poor reproducibility in perfusion signal based on test-retest analysis

4.4.2 Pattern analysis of placental blood flow distribution in ASL MRI of
human pregnancy
In Fig. 20 shows box plots of selected cluster metrics (Total Area, % Area, and Mean). When
comparing individuals with no gestational hypertension and those with gestational hypertension, it
appears that the latter group demonstrates larger within-subject variability of Total Area and %
Area in the 100 samples of the posterior distribution compared to the former group (Fig. 20a,b).
The Mean signal of the gestational hypertensive subjects appears to be about the same or
slightly lower than the non-hypertensive subjects (Fig. 20c).

b
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Figure 20 Per subject box plots of 2.5%,50%,97.5% quantiles for select cluster metrics. For
Total Area (a) and % Area (b), subjects with gestational hypertension (red) have similar
median and larger posterior variances compared to subjects without gestational
hypertension (green). For Mean (c), subjects with gestational hypertension appear to have
about the same median as or lower than the non-hypertensive subjects.

69

4.5 Discussion
In these studies, background suppressed 1.5T FAIR ASL was found to be feasible in second and
third trimester pregnancies and suitable for pattern analysis to better understand blood flow
distribution in the placenta. The control-label difference signal changes yielded a TI dependence
consistent with ASL theory and provided reproducible maps of placental blood flow. As expected,
placental perfusion was highest in the ROI comprised of the voxels with the most significant
label/control effect. Note that placental “perfusion” is not homogeneous, but rather signal changes
are localized to discrete regions likely representing the distributions of individual spiral arteries,
which deliver blood to chorionic villi. Some of these spiral artery distributions are found to be
infarcted in patients with fetal growth retardation [75], and placental ASL provides a potential
approach for detecting this pathology in vivo. Placental blood flow values were in the range of
previously published values [23, 24], though when averaged across the anatomically defined ROI,
values were considerably lower.
An alternative approach of measuring blood flow distribution in the placenta rather than traditional
perfusion was shown to be feasible in this ASL dataset. This approach did not assume a
perfusion model in characterizing the open circulation of the intervillous space, thus allowing the
opportunity for understanding the unique potential blood flow dynamics directly from the data.
Initial results showed promise in distinguishing between normotensive and gestational
hypertension subjects by showing the second group had a larger within-subject variability in the
total area and percent area of blood flow clusters over scan duration. This pattern may be related
to more motion or intermittent flow in the abnormal pregnancies. Although a larger subject
population would be needed to confirm the clinically relevant differences seen, it is possible
based on initial evidence that these patterns can be related to placental lobular morphology and
function. For example, placental infarcts may manifest as reduced density of blood flow
distribution.
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In future work, this ASL acquisition and signal processing method can be improved upon by
extending to 3D coverage of the placenta. Simultaneous-Multislice (SMS) and accelerated
imaging strategies can be used to greatly increase the slice coverage. Another potential
improvement is finer and larger range sampling of TIs, particularly shorter TIs less than 150 ms,
to better capture temporal perfusion dynamics.

4.6 Conclusions
These studies demonstrated the feasibility of measuring and quantifying placental blood flow in
healthy pregnant subjects in the second and third trimester using background suppressed FAIR
ASL at 1.5T. Placental ASL with Bayesian statistics provides an approach for noninvasively
mapping and evaluating maternal blood flow pattern in the placenta. Metrics quantifying
characteristics of HPD-related placental dysfunction can potentially be clinically relevant
biomarkers for assessing risk of adverse pregnancy outcomes.
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CHAPTER 5: NON-INVASIVE IMAGING OF THE UTERINE
ARTERY DURING HUMAN PREGNANCY WITH UTERINE
ARTERY US, 4D FLOW MRI, AND TIME-OF-FLIGHT (TOF) MRI
5.1 Conventional uterine artery assessment by Doppler ultrasound (US)
Clinicians have largely relied on Doppler ultrasound velocimetry of the UtAs as an indirect
measure of placental hemodynamics in suspected HPD patients based on the notion that
pathologic high resistance to flow in the poorly remodeled spiral arteries would be reflected in the
upstream UtAs, particularly after 24 weeks gestation. This approach is feasible because the UtAs
are larger (3-5 mm in diameter) than the spiral arteries (~300 µm) and can be reliably localized.
UtA velocity waveforms are commonly measured using a transabdominal probe at the lower
uterus near the inguinal ligament. Historically UtA velocity was first measured using continuous
wave Doppler [137, 138], but later with the availability of color pulsed wave Doppler the UtA
became easier to locate. The key feature for finding the UtA is the crossover between the vessel
and the external iliac artery. The sonographer rotates the probe until the characteristic spectral
Doppler waveform is found. In nonpregnant and early first trimester subjects, the velocity
waveform of the UtA has a sharp systolic peak and a low velocity diastolic phase, called a
diastolic notch. By the end of the second trimester, it normally converts to a sharp systolic peak
with a steady positive diastolic phase, indicating reduced resistance to flow [92].
When studies began to show that adverse pregnancy outcomes seemed to be correlated with a
persistent diastolic notch in late pregnancy, researchers began reporting metrics to identify
abnormal UtA waveforms in pregnancy cohorts. Systolic/diastolic ratio, resistance index, and
pulsatility index were used to circumvent the need to adjust for the insonation angle, which must
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be considered to accurately quantify velocity. Nomograms and statistical thresholds were
subsequently developed to categorize patients into low-risk and high-risk categories for HPD
[139-141].

5.2 Assessment of the uterine artery structure and hemodynamics by 4D
flow and TOF MRI
5.2.1 Abstract
Given the challenges associated with uterine artery Doppler ultrasound, MRI was investigated as
an alternative imaging technique for HPD. The purpose of this study was to determine the
feasibility of 4D flow MRI in pregnant subjects by characterizing UtA anatomy, computing UtA
flow, and comparing UtA velocity, pulsatility and resistivity indices (PI, RI) with transabdominal
Doppler US.
In a prospective cross-sectional study from June 6, 2016 to May 2, 2018, non-contrast
angiography and 4D flow MRI of the UtA and placenta using 1.5T were performed for forty-one
singleton pregnant subjects (age [range]=27.0±5.9 [18-41] years) in their second or third
trimester. We additionally scanned three subjects who had pre-pregnancy diabetes or chronic
hypertension. UtA anatomy was described based on 4D flow-derived non-contrast angiography,
while UtA flow properties were characterized by net flow, systolic/mean/diastolic velocity, PI and
RI through examination of 4D flow data. PI and RI are standard hemodynamic parameters
routinely reported on Doppler US. Spearman’s rank correlation, Wilcoxon signed rank tests, and
Bland-Altman plots were used to preliminarily investigate the relationships between flow
parameters, gestational age, and Doppler US.
4D flow MRI and UtA flow quantification was feasible in all subjects. There was considerable
heterogeneity in UtA geometry in each subject between left and right UtAs and between subjects.
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Mean 4D flow-based parameters were: mean bilateral flow rate=605.6±220.5 mL/min,
PI=0.72±0.2, and RI=0.47±0.1. Bilateral flow did not change with gestational age. We found that
MRI differed from US, showing lower PI (mean difference -0.1) and RI (mean difference <-0.1)
with Wilcoxon signed rank test results of p=0.05 and p=0.13, respectively. 4D flow MRI was
shown to be a feasible approach for describing UtA anatomy and flow in pregnant subjects.

5.2.2 Introduction
The placenta plays an essential role in supporting the endocrine, nutritional, and oxygenation
needs of the growing fetus [54]. During gestation, the maternal uterine arteries (UtA) undergo
extensive remodeling, hypertrophy and hyperplasia of vascular smooth muscle, and decreased
arterial impedance to match fetal demand for oxygen and nutrients [46]. Arterial dysfunction is
characteristic of pregnancy disorders (e.g. preeclampsia and fetal growth restriction) and reduced
UtA flow is implicated in reduced birth weight and spontaneous preterm birth [142]. Quantitative
parameters that can characterize abnormal UtA remodeling and reduced UtA flow may provide
effective screening tools to identify women who have the greatest risk for adverse pregnancy
outcomes.
Transabdominal Doppler ultrasound (US) is the primary method used to assess UtA flow but is
challenging due to the heterogeneous and tortuous UtA anatomy, location, and dependence of
measured velocity on insonation angle [21]. Some of the limitations of US may be addressed with
2D phase contrast MRI [20, 21], but this is also challenged by difficulty planning 2D plane
locations, lack of three-dimensional anatomy visualization, and, in the case of unidirectional
velocity encoding, dependence of flow direction on the plane angle.
Time-resolved 3D phase contrast imaging (“4D flow”) is an MRI technique that maps all three
spatial components of blood and shows 3D arterial morphology and flow dynamics. While we do
not anticipate this method to be readily leveraged in standard clinical practice, it may be useful for
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research as it enables assessment of blood flow in highly tortuous vessels such as the UtAs, with
reduced operator dependence compared to US [22, 143, 144]. Compared to 2D phase contrast
MRI, 4D flow requires longer scan times to achieve the spatial coverage and spatial resolution
needed to image the UtA. As a result, fetal or maternal respiratory motion may corrupt 4D flow
data.
The purpose of this study was to assess the feasibility of obtaining 4D flow MRI data in pregnant
subjects. A second objective was to characterize UtA structure and hemodynamics using 4D flow
and compare these results to Doppler US.

5.2.3 Methods
5.2.3.1 Study Population
This study was completed on forty-one pregnant subjects (50 originally enrolled) who gave
informed consent between June 6, 2016 and May 2, 2018 to be enrolled in this cross-sectional
study approved by the HIPAA-compliant Institutional Review Board. Inclusion criteria included
singleton gestations at 16 weeks or greater. Exclusion criteria were: (1) morbid obesity (BMI ≥ 35
at the start of the pregnancy), (2) uterine fibroids and major structural fetal anomaly, (3) routine
MRI contraindications such as metallic implants/devices and claustrophobia, (4) insufficient MRI
image quality, and (5) lack of US scan for comparison. The 9 subjects who underwent MRI and
were excluded from analysis are reported in Figure 21, leaving a final count of forty-one females
for whom data analysis was completed. Reasons for exclusion from the data analysis were:
incorrect setting of maximum velocity encoding threshold (VENC) parameter (n=4), the attending
physician was not available for Doppler US (n=5), or one UtA could not be located on either MRI
or US but the other UtA remained in the dataset (n=3). Additionally, we scanned and analyzed
three subjects with more serious risk factors of adverse pregnancy (one with pre-pregnancy
diabetes mellitus and two with chronic hypertension).
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50 subjects, 100 UtAs
Diameter (mm)
measured on TOF
Excluded 4 early scans because
VENC <100 cm/s
Excluded 3 UtAs not found on
either US or MRI

46 subjects, 89 UtAs

Excluded 5 scans
because no US

41 subjects, 79 UtAs
4 planes per UtA
analyzed with 4D flow
with calculations of
velocity (cm/s), total flow
(mL/min), PI, and RI.
MRI vs. US comparison

Figure 21 Diagram of exclusion criteria for analysis.

5.2.3.2 Ultrasound
Doppler US was collected and analyzed in forty-one subjects (E10 Voluson; GE Healthcare,
Chicago, IL). US measurements of blood flow velocity in the left and right UtAs were acquired
using a transabdominal probe. Real-time color velocimetry allowed for identification of the
intersection between the uterine and external iliac arteries, and velocity waveforms were recorded
according to standard guidelines [96]. Following a standard routine protocol, the angle of
insonation between probe and UtA was kept as close to zero as possible, and in all cases <30
degrees. Angle correction was used when a zero angle was not obtainable. MRI-compatible
fiducials were adhered to each side of the surface of the abdomen bilaterally where the US probe
had been located for identification of spatial correspondence on subsequent MRI.
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5.2.3.3 Magnetic Resonance Imaging
MRI was performed at 1.5T (Avanto; Siemens Healthcare, Erlangen, Germany) with a 12-channel
spine array and 4-channel body array coil. 37 subjects were in supine position and 4 subjects
were in left lateral decubitus position based on their individual comfort level. 3-lead ECG leads
were used for cardiac-gated acquisitions. Anatomical localization of the abdomen and placenta
was obtained with a half-Fourier acquisition stimulated echo (HASTE) sequence.
An ECG-gated 2D multislice axial time-of-flight (TOF) angiogram was acquired, including the
bifurcation of the descending aorta and the top of the femoral heads of the thigh bones based on
the HASTE images to ensure coverage of the UtAs near the internal uterine orifice (Figure 22).
The imaging parameters are listed in Table 4. Details of TOF parameter optimization are provided
in Figure 23.

A. MRI Image Acquisition
i. HASTE

(R arcuate artery)

C. Velocity Waveform
Analysis

iii. 4D flow (3D phase contrast)

ii. TOF angiogram

i. Bilateral flow vs. GA
(4D flow only)

(L arcuate artery)
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ii. 4D flow vs. US comparison
R UtA
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B. 4D Flow Preprocessing and Analysis
i. Background noise masking
Manual anti-aliasing

ii. Manual segmentation
(optional, used only for 6 subjects in Fig. 4)

iii. Velocity-based thresholding
Plane prescription

iv. Vessel contour segmentation

v. Velocity profile
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Figure 22 Methodology workflow. A, MRI Image Acquisition. The TOF scan (A.ii) was
planned from a HASTE localizer (A.i). The 4D flow scan (A.iii) was positioned at the UtA
hairpin using the TOF scan as a reference. The overall scan time was 30-40 minutes. B, 4D
Flow Preprocessing and Analysis. The 4D flow analysis included phase difference image
noise filtering and, if needed, manual anti-aliasing (B.i). For improved visualization in the
subjects in Fig. 25, optional manual segmentation of UtA from 4D flow-generated
angiograms (B.ii) was used in addition to velocity-based thresholding. Velocity-based
thresholding was performed to create volumetric isosurfaces, from which four
measurement planes were distributed along the UtA and oriented perpendicular to the
blood flow (B.iii). The vessel was segmented (B.iv) and velocity profiles (B.v) were
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extracted from each plane at each phase. C, Velocity Waveform Analysis. Flow (Q),
systolic velocity (vmax), diastolic velocity (vmin), mean velocity (!), pulsatility (PI), and
resistivity indices (RI) were estimated. We compared MRI and US in the corresponding
UtAs of each subject.

Time-of-Flight

4D flow

Flip angle

50 degrees

8 degrees

TR/TE

394/4.4 ms

5.5/2.67-3.13 ms

FOV

350 x 208-330 x 140-280 mm

Voxel size

1.1 x 1.1 x 2.8 mm

BW/pixel

200 Hz/pixel

445-455 Hz/pixel

Segments/shot

N/A

2

Temporal resolution

N/A

42.4-46.4 ms

# Cardiac phases

N/A

10-18

Acceleration factor

N/A

4.7

VENC

N/A

50-200 cm/s

Acquisition time

7-12 min.

12-20 min.

3

3

192-320 x 176-320 x
3
16-174 mm
1.17-2 x1.17-2 x1-2
3
mm

Abbreviations: FOV=field-of-view; BW/pixel=bandwidth per pixel; VENC=velocity encoding;
TOF=time-of-flight
Table 4 Summary of uterine artery TOF and 4D flow MRI parameters.
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Figure 23 Comparison of TOF saturation schemes: a) saturation band that follows axial
multi-slice acquisition from inferior to superior in an excluded subject, b) stationary
saturation band below the uterine arteries in Subject 8, c) no saturation band in Subject
20. The stationary saturation band provided uterine artery details without displaying
extensive venous signal contamination. Details on how saturation configuration relates to
direction of blood flow in 2D TOF angiography can be found in [108].
4D flow MRI was obtained with a prospectively-gated time-resolved 3D phase contrast sequence
with three-directional velocity encoding. Each cine cardiac phase consisted of four-point velocity
encoding, 2 segments/shot, and 5.5 ms TR resulting in a temporal resolution of 8TR=44 ms.
Other imaging parameters were as follows: Parallel MRI With Extended and Averaged
GeneRalized Autocalibrating Partial Parallel Acquisition Kernels (PEAK-GRAPPA) acceleration
factor=4.7 [145], velocity encoding parameter (VENC)=50-200 cm/s [22], acquisition time=12-20
min., number of cardiac phases=10-18 (Table 4). To reduce scan time, respiratory navigation or
gating was not used. Online phase difference reconstruction with Maxwell correction of
concomitant gradient terms was performed from the scanner [108, 146].

5.2.3.4 Image Analysis
MRI Vascular Geometry Analysis
The diameter of the UtAs were measured in the TOF multiplanar reformats at the location of
intersection between the UtA and the external iliac artery on each side. Measuring the diameter of
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the UtAs with US was not part of the study and therefore no area measurements were obtained to
compute flow rate from US.
4D Flow MRI Data Analysis
Phase difference images from all the subjects were filtered and received anti-aliasing correction,
if present (Figure 22.B.i), using custom software (Matlab; The MathWorks, Natick, MA, USA)
[147]. Image noise was removed by magnitude image thresholding. All pixels below the threshold
were removed from magnitude and phase data. Anti-aliasing was performed by phase
unwrapping [148].
For the six subjects in Figure 25, additional masking was performed to reduce residual signal
from outside the vessel regions (Figure 22.B.ii). Mean magnitude-weighted velocity phase
contrast angiograms were generated as described in [147-149]. Additional manual segmentation
was performed (Seg3D; Univ. of Utah SCI). The resulting binary segmentation was used to mask
the magnitude and phase difference images.
For all subjects, filtered magnitude and phase difference images were imported into flow analysis
software (Ensight, CEI; Apex, NC). A vascular isosurface was generated by thresholding the
phase difference images. Eight planes were selected along the UtAs (four on each side), with the
plane normal oriented parallel to the flow direction. The planes were distributed uniformly
between the branching point of the internal iliac artery and UtA and the intersection of the UtA
and the external iliac artery. The distal location was confirmed by fiducial markers placed during
US as described in the methods section. Pathlines were generated to visualize the movement of
blood for confirming the direction of flow and data visualization. The vessel lumen was
segmented at each time point, and velocity profiles were generated (Figure 22.B.iii-v).
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Subject 16

Subject 25

Subject 30

Subject A

Subject B

Subject C

Condition/Outcome

Normal

Normal

Normal

Pre-pregnancy diabetes

Chronic hypertension

Chronic hypertension

GA (#weeks#days)

24w3d

26w5d

29w4d

26w4d

36w0d

36w3d

22

27

23

32

23

20

Posterior, far right

Anterior, center

Anterior, center

Posterior, center

Posterior, left

Posterior

Maternal age (years)

Placental position

TOF Angiogram

Figure 24 Gestational age (GA), maternal age, placental position, and time-of-flight (TOF)
angiogram of the pelvic arteries in three representative subjects (16, 25, 30) and three
abnormal subjects (A, B, C).

Figure 25 Uterine artery surface renderings obtained from 4D flow in three representative
subjects and three abnormal subjects. There was considerable intersubject and
intrasubject heterogeneity in the geometrical structure of the hairpin loop of the pelvic
uterine arteries.
Velocity Analysis
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4D flow phase difference images provided 3D velocity information to generate a time-resolved
waveform for each plane. Let vector ! = #$ , #& , #' at each voxel represent velocity in cm/s and !

be the unit normal vector to the plane pointing in the direction of blood flow. Let !" = $ ∙ & be the
scalar component of the velocity vector along ! and parameterized as !" ($, &) where
! ∈ {1, … , '}|'=number of voxels in the prescribed plane and ! ∈ {1, … , '}|'=number of cardiac

phases in one RR interval. Spatial peak and mean velocity are defined for each phase as
!",$ (&) = max, !" (-, &) and !",$ (&) =

!",$% =

./0 )* (+,,)

, respectively. Temporal mean velocity is defined as

1

- ' (+)
./0 (,)

%

. Time-resolved waveforms were generated from the spatial peak and mean

velocities, !",$ (&) and !",$ (&) , at each plane. Since 4D flow was a prospectively-gated scan, some
cardiac phases were not collected during end-diastole. Missing data were extrapolated by filling
the rest of the RR interval with the average between the first and last measured velocity.
Flow (Q) [mL/min] was computed from the spatial mean velocity waveforms from 4D flow.
Pulsatility index (PI) and resistivity index (RI) were computed from both the spatial peak velocity
waveforms from 4D flow and the Doppler velocity waveforms from US:
!

$%&

Q="" ∙ '() ∙

PI=

RI=

82

123
12% *+,- (/),

!"#$ %&,( (*)- !-.$ %&,( *
%&,(/

!"#$ %&,( (*)- !-.$ %&,( *
!"#$ %&,( (*)

, and

, where

!=cross-sectional area, RR=RR interval (sec), max$ %&,( (*)=systolic velocity, min$ %&,( ) =diastolic

velocity, and !",$%=temporal mean velocity.

Q, PI, and RI were computed for each plane and were subsequently averaged together across
the four planes per vessel. PI and RI were computed from the 4D flow MRI and US waveforms for
comparison. For each subject, unilateral flow coefficient-of-variation (CoV) was determined.
Intrascan reliability and inter- and intra-observer measurement reliability was performed. Most
measurements had strong reliability (Table 7).

5.2.3.5 Statistical Analysis
Descriptive statistics are reported as mean±standard deviation(SD). Tests for statistical normality
were performed on the 41 subjects were performed for statistical normality using the Shapiro-Wilk
test and for heteroscedasticity using the Bartlett’s and Breusch-Pagan tests. Correlations
between variables were assessed by computing Pearson’s R correlation coefficient for MRI flow
rate and Spearman’s rank correlation coefficients (rho) for US and MRI velocity parameters.
Comparisons between modalities were reported using Wilcoxon signed rank tests and BlandAltman plots. Statistical significance was defined as p<0.05.

5.2.4 Results
5.2.4.1 Subject Characteristics
26 subjects were recruited in the second trimester and 15 subjects in the third trimester. Subjects
had a maternal weight=74.8±13.6 kg and gestational age (GA)= 26.0±5.1 (range=18-38) weeks.
Individual subject information is summarized in Table 5. 4D flow MRI was acquired and welltolerated in all subjects.
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ID

Maternal age
(y)

Maternal
height
(cm)

Maternal weight
(kg)

1

18

157

74

18w1d

unknown

2

34

155

49

18w3d

G1P0

3

32

170

82

18w4d

G1P0

4

18

165

62

18w5d

unknown

5

24

163

86

18w6d

G4P3

6

30

unknown

59

19w0d

G1P0

7

21

163

86

21w5d

G2P1

8

30

168

75

22w4d

G1P0

9

26

160

56

22w5d

G1P0

10

34

163

60

22w6d

G2P1

11

25

147

64

23w3d

G2P1

12

26

170

77

23w4d

G2P1

13

31

160

80

23w4d

G7P6

14

23

170

65

23w5d

G2P1

15

22

165

93

24w3d

G3P2

16

26

173

66

24w4d

G3P2

17

23

165

81

24w4d

G1P0

18

28

173

88

24w4d

unknown

19

20

155

57

25w3d

G3P2

20

33

168

85

25w3d

G2P1

21

19

175

106

25w4d

G1P0

22

41

157

66

25w5d

G3P2

23

34

152

68

25w5d

G3P2

24

32

178

89

26w4d

G3P2

25

27

160

56

26w5d

G3P2

84

Gestational Age
(#weeks#days)

Gravidity and
Parity

26

22

157

81

26w6d

G3P2

27

35

156

63

27w6d

G2P1

28

19

165

80

28w5d

G1P0

29

39

175

93

28w6d

G4P3

30

23

150

55

29w4d

G1P0

31

21

157

80

29w4d

unknown

32

28

157

74

29w6d

G2P1

33

31

165

65

30w3d

G2P1

34

26

168

86

30w3d

G1P0

35

34

170

69

31w1d

G1P0

36

21

170

92

31w2d

G1P0

37

25

157

86

31w4d

G4P1

38

20

170

56

32w6d

G1P0

39

33

165

88

35w4d

G5P4

40

28

168

96

37w2d

G5P4

41

32

170

82

37w3d

G2P1

Abbreviations: G=gravidity, P=parity
Table 5 Subject demographic data

5.2.4.2 Uterine Artery Anatomy in Second and Third Trimester
In all subjects, right and left UtAs branched from the internal iliac artery, became a tortuous
hairpin proximally, made a 180° turn from superior-inferior (SI) to IS trajectory, and became a
distal straight segment towards the uterus before additional branching at the arcuate artery. UtA
proximal segments were predominantly medial while distal segments were lateral and intersected
the external iliac arteries at locations confirmed by MRI-compatible fiducials. Average UtA
diameter within the imaged extent was 4.05±0.7 mm.
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There was considerable inter- and intrasubject anatomical heterogeneity. GA, maternal age,
maternal MRI position, placental position, and arterial TOF angiograms of six representative
subjects are shown in Figure 24. Figure 25 shows heterogeneity in the geometry of the left and
right UtA from the same six representative subjects (see also Supplementary Video 1 in [150]).

5.2.4.3 Uterine Artery Hemodynamics
Hemodynamic measurements from 4D flow MRI were reported as the average of measurements
in four planes. Flow in the left UtA was !" =291±111 mL/min, right UtA was !" =322±147 mL/min,
and bilateral (total) flow was !" =606±221 mL/min. Flow rate measurement reliability statistics are
reported in Section 5.2.4.5 and Table 7. There was no association between UtA bilateral flow
2

and GA in these subjects (R =0.01, p=0.49) (Figure 26). UtA structure and hemodynamics are
shown using pathlines derived from one representative subject in Figure 27 and Supplementary
Video 2 in [150].
MRI differed from US in terms of PI (0.72±0.26 vs. 0.84±0.42, p=0.05) and RI (0.47±0.11 vs.
0.50±0.11, p=0.13) based on Wilcoxon signed rank tests (Figure 28). MRI and US were also
moderately correlated in terms of systolic velocity (ρ=0.39, p<<0.01), diastolic velocity (ρ=0.42,
p<<0.01), mean velocity (ρ=0.44, p<<0.01) (Figure 29), PI (ρ=0.37, p<<0.01), and RI (ρ=0.38,
p<<0.01) (Figure 30).
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Figure 26 Scatter plot of flow vs. gestational age across forty-one subjects with results
from a linear fit and Pearson’s correlation analysis including 95% confidence interval (gray
region). Red dots indicate abnormal subjects (A,B,C).
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Figure 27 a) The eight 4D flow planes, four planes on each side, distributed along the UtAs
in Subject 30. Planes R4 and L4 were estimated to correspond with the location of Doppler
US velocity measurements. The interpolated velocity profiles of planes R1 (b), R2 (c), R3
(d), and R4 (e) are shown.
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a

b
B

C

A

p=0.05

c

d
B
C

A

p=0.13

Figure 28 Box-and-whisker and Bland-Altman plots of pulsatility index (a,b) and resistivity
index (c,d) comparing MRI and US.

5.2.4.4 Feasibility in Subjects with Risk Factors for Adverse Pregnancy
We separately identified three subjects with representative risk factors for adverse pregnancy,
one with pre-pregnancy diabetes mellitus and two with chronic hypertension. In these subjects,
4D flow MRI was feasible. Individual subject information is reported in Table 6. For Subject A with
diabetes, we measured !" =655.5 mL/min and average unilateral PI=0.61. For Subject B with
chronic hypertension, we measured !" =502.4 mL/min and PI=0.75. For Subject C with chronic
hypertension, we measured !" =904.4 mL/min and PI=0.57. These results demonstrate that
measurement of these hemodynamic parameters were feasible in abnormal pregnant subjects
with 4D flow MRI. These subjects are presented in Figure 24 and Figure 25. Their results are
annotated in Figures 26, 28-30.
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Maternal
age (y)

Maternal
height
(cm)

Maternal weight
(kg)

A

25

175

84

B

23

160

C

20

168

ID

Gestational
Age

Gravidity and
Parity

Risk Factor

19w1d

unknown

Diabetes
mellitus

83

36w0d

G1P0

Chronic
hypertension

96

36w3d

G2P1

Chronic
hypertension

(#weeks#days)

Table 6 Abnormal subject demographic data

89

Figure 29 Box-and-whisker, Spearman’s rho correlation coefficients with linear fit, and
Bland-Altman plots comparing MRI and US in terms of systolic velocity (a,b,c), diastolic
velocity (d,e,f), and mean velocity (g,h,i).
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Figure 30 Spearman’s rho correlation coefficients with linear fit comparing MRI and US in
terms of PI (a) and RI (b).

5.2.4.5 Reliability analysis of 4D flow MRI measurements
We include supplementary information reported in Hwuang et al. [150] to further discuss the
reliability of 4D flow MRI by taking into account potential confounders. This section provides
details on how 4D flow MRI was assessed in terms of: 1) reliability in repeated measurements of
flow rate, 2) comparison with US after removing temporal resolution differences, and 3) eddy
current correction.
Flow Rate Reliability Analysis
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To determine scan-rescan reliability of step A.iii (Figure 22), two subjects were scanned twice
consecutively in an imaging session and the intraclass correlation coefficient (ICC) of the flow
rate was determined. To determine interobserver measurement reliability, two users each
performed post-processing steps B.i, B.iii, B.iv (Figure 22) and the ICC was determined for
bilateral and unilateral flow. To determine intraobserver measurement reliability, one user
performed post-processing steps B.i, B.iii, B.iv and B.iv (contouring alone) and the ICC was
determined for bilateral and unilateral flow. Scan-rescan, interobserver, and intraobserver
reliability were measured by ICC(consistency) and ICC(absolute agreement) based on results
from two-way analysis of variance (ANOVA) without replication using the procedure described in
[151]. The results are reported in Table 7. We also measured the variation across the four planes
prescribed in each UtA in the forty-one subjects. The average of standard deviation across the
four planes was 78.9 mL/min in the right UtA and 68.5 mL/min in the left UtA. The coefficient of
variation of unilateral flow was 27.4±16.6% in the right UtA and 24.0±10.6% in the left UtA.
Scenario in which Q was measured:

ICC (consistency)

ICC (absolute
agreement)

1. Unilateral flow intrascan reliability
(n=2)^

0.99

0.83

2. Bilateral flow measurement
interobserver reliability n=5)*

0.98

0.86

3. Unilateral flow measurement
interobserver reliability (n=5)*

0.98

0.89

4. Bilateral flow measurement
intraobserver reliability (n=5)*

0.90

0.68

5. Unilateral flow measurement
intraobserver reliability (n=5)*

0.89

0.79

6. Unilateral flow measurement
intraobserver reliability (n=1)#

>0.99

>0.99

^reliability of step A.iii of Figure 22
*reliability of steps B.i, B.iii, and B.iv of Figure 22
#reliability of step B.iv of Figure 22
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Table 7 ICC results for reliability experiments with repeated flow rate measurements using
4D flow. ICC (consistency) and ICC (absolute agreement) were computed from the results
of a two-way ANOVA.
Temporal Resolution in MRI-US Comparisons
We were interested in seeing if the difference in temporal resolution between MRI and US played
a role in the agreement between the two modalities when measuring velocity-based parameters.
While the US parameters reported in the main text were given by the US machine, we separately
processed the waveforms for this supplementary analysis. The US velocity waveforms from each
UtA were extracted from the images by cropping, binary thresholding, and edge detection in
MATLAB (MathWorks; Natick, MA). The US data (~160-360 points/cardiac cycle) was
downsampled to match the temporal resolution of 4D flow MRI (~14 cardiac phases). We then
repeated the MRI-US comparative statistical analyses (Wilcoxon signed rank test, Spearman’s
rho correlation coefficient, and Bland-Altman plot) with the downsampled version of the US
waveforms. The results are reported in Table 8. In general, it appears that the downsampled US
measurements were closer than the original US machine measurements to the MRI
measurements, indicating that the difference in temporal resolution may play a role in the
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Mean difference [95%
limits of agreement]

[-77.5,52.8]

MRI-USds

-12.3

MRI-US

[-84.3,52.3]

MRI vs.
USds

-16.0

MRI vs.
US

p<<0.01*

MRI
vs.
USds

ρ=0.41

MRI
vs.
US

p<<0.01*

ρ

ρ=0.39

Wilcoxon

p<<0.01*

USds

96.2±35.1

US

99.9±36.7

83.8±25.3

Systolic
velocity
(cm/s)

MRI

p<<0.01*

agreement between MRI and US.

[-46.6,37.9]
[-1.1,0.8]
[-0.3,0.2]

[-52.5,44.0]

-4.4
-0.2
<-0.1

-4.3

[-50.6,37.6]
[-0.9,0.7]
[-0.3,0.2]

[-57.2,43.8]

-6.5
-0.1
<-0.1

-6.7

p<<0.01*
p<<0.01*
p<<0.01*

p<<0.01*

ρ=0.49
ρ=0.49
ρ=0.37
ρ=0.40

p<<0.01*
p<<0.01*
p<<0.01*

p<<0.01*

ρ=0.42
ρ=0.37
ρ=0.38

ρ=0.44

p=0.12
p=0.17
p=0.02*
p=0.04*

p=0.01*
p=0.05*
p=0.13

p=0.02*

48.5±23.6
0.88±0.53
0.51±0.13

63.1±27.4

50.6±23.7
0.84±0.42
0.50±0.11

65.6±27.8

44.1±16.5
0.72±0.26
0.47±0.11

58.9±19.5

Diastolic
velocity
(cm/s)
Mean
velocity
(cm/s)
PI (A.U.)
RI (A.U.)

*Wilcoxon or Spearman’s rho, p<0.05
Table 8 Comparison of MRI, US, and downsampled US (USds) velocity-based parameters.
We report mean±standard deviation, Wilcoxon signed rank test p-value, Spearman’s rho
correlation coefficient (ρ) with p-value, and Bland-Altman mean difference with limits of
agreement based on a 95% confidence interval.
Eddy Current Correction
While we did not perform eddy current correction (ECC) in the original 4D flow cohort, we were
interested in assessing the impact of ECC on the results. Therefore, in six subjects we performed
steps B and C (Figure 22) with the addition of eddy current correction using custom software
(Matlab; The MathWorks, Natick, MA, USA) developed by UKL Freiburg and NU Radiology [147].
We report ICC between flow measurements generated with and without ECC (Table 9). The
paired Wilcoxon signed rank test between the two versions of unilateral flow was not significant
(p=0.08). We also present a Bland-Altman plot of unilateral flow rate (Figure 31).
Scenario in which Q was measured:
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ICC (consistency)

ICC (absolute agreement)

1. Bilateral flow measurement (n=5)*

0.86

0.84

2. Unilateral flow measurement (n=5)*

0.92

0.89

Table 9 Comparison of flow measurements using 4D flow with and without eddy current
correction.

Figure 31 Bland-Altman plot of unilateral UtA flow rate measured with 4D flow MRI with
and without eddy current correction (ECC). The mean difference was 35.12 mL/min with
95% limits of agreement [-73.57,143.8] mL/min.

5.2.5 Discussion
We report the feasibility of UtA anatomical and hemodynamic assessment in second and third
trimester pregnant subjects using 4D flow MRI acquired at 1.5T. 4D flow images enabled detailed
characterization of the UtA blood flow, independent of the orientation of the examination plane,
and at locations inaccessible to US. After branching from the internal iliac artery, the tortuous UtA
traversed inferiorly and medially, formed a hairpin loop in the pelvis, and subsequently carried
blood superiorly and laterally to radial and spiral arteries. This anatomy has been partly described
in embolization procedures for peripartum hemorrhage [152, 153], however there is limited
knowledge of its normal and pathophysiologic anatomical variation. We observed substantial
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bilateral UtA anatomical and hemodynamic heterogeneity, which may reflect variations in
placental location, molecular signals that promote UtA remodeling and growth, body habitus, and
variations in patient position during imaging.
UtA diameter derived from TOF agreed with previous reports obtained using 2D phase contrast
MRI [20, 154] and US [63, 155]. UtA outward hypertropic remodeling occurs throughout gestation
and the vessel cross-sectional area enlarges [46, 63, 155]. Similar positive associations between
flow rate and GA have also been reported [63, 142]. These studies show a moderate association
between flow and GA in the first trimester [142], but a comparatively weaker association in the
second and third trimester [63], suggesting that the most extensive UtA remodeling occurs during
the first trimester. Our findings in second and third trimester subjects were consistent with this,
and no substantial blood flow changes in the late second and third trimesters were found. This
contrasts with fetal weight growth, which is slower in the first two trimesters than the third [105].
Altogether, these findings suggest that during early placental development the UtAs are primed to
increase blood flow so that the placenta may have sufficient reserve to accommodate changes in
fetal oxygen demand during late gestation. Failure of UtA growth and remodeling with placental
dysfunction in the first trimester may limit fetal growth in later trimesters.
There was moderate correlation between PI and RI obtained using MRI and US, which was
consistent with prior observations using 2D phase contrast MRI [21]. However, some observed
discordance between MRI and US may be attributed to hemodynamic differences caused by
body habitus [156] during MRI (mostly supine) and US (inclined supine), location of
measurement, and differences in temporal and spatial resolution. Previous studies have reported
flow rate measured with US [142, 155, 157] but this was omitted in this study. US-based flow rate
requires measurement of diameter, which has not yet been standardized in obstetric research
because the UtA lumen is not always clearly visible from low spatial resolution and vessel
tortuosity.
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Time-resolved three-dimensional velocity field data can be used to compute additional complex
flow parameters such as relative pressure gradients [158], pulse wave velocity [159], and wall
shear stress [159]. These flow parameters in the UtA may provide new predictive markers of
pregnancy health in early gestation. Decreased vascular resistance at the uteroplacental junction
increases UtA blood flow, which may increase wall shear stress and stimulate endothelial
production of nitric oxide (NO) [46, 60, 160]. Targeted therapies such as dietary arginine
supplementation may increase NO production, vasodilatory remodeling, and improve UtA flow
[13]. Additional imaging markers may improve the predictive value of these studies.
All MRI scans performed in this study were below the limit mandated by the United States Food
and Drug Administration (FDA). No additional restrictions were placed on the hardware beyond
the current FDA limitations on rate of time-varying magnetic fields (dB/dt) and maximum
allowable specific absorption rate (SAR). While caution is recommended when imaging obstetric
patients, most recent guidelines have identified MRI to be safe in this population because
concerns about harm to the fetus remain theoretical with no established clinical evidence [161,
162]. The American College of Radiology states that no special considerations need to be made
for women in their first trimester more than any other trimester [163]. Studies of MRI in pregnancy
have shown MRI exposure to not pose a concern for adverse fetal outcome in the first trimester
[126] and after the first trimester [164, 165]. In this study, no additional safety considerations were
enforced beyond the FDA requirements.
This cross-sectional study may be affected by physiologic subject variation (e.g. height, weight,
and internal iliac branching geometry) that can potentially be reduced with a longitudinal study.
Subjects can also vary in the distribution of flow between the uterine and ovarian arteries. As a
result, interpretations about placental perfusion from only UtA flow assessment can be
misleading. It is possible that the ovarian arteries also remodel during gestation because the PI
has been found to be lower than in non-pregnant subjects similar to the UtA [166, 167]. There are
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also some limitations of 4D flow assessment of UtA function. The tortuous UtAs may cause MRI
acceleration and displacement artifacts such as inaccurate velocity encoding and spatial
encoding. The current spatial resolution may preclude accurate flow quantification in the first
trimester. In non-pregnant subjects scanned during protocol development, we observed that the
UtA was not readily visible. Even when the UtA is visible in pregnant subjects, three voxels span
the vessel at best, which does not allow the calculation of pressure gradient or wall shear stress.
Pulse wave velocity can possibly be calculated with high temporal resolution or a long vessel path
to compensate for low spatial resolution. Nevertheless, our 4D flow acquisition has a spatial
resolution that is superior to the state-of-the-art of 2D PC acquired of the UtA reported in [154].
Respiratory gating was not performed in our subjects to reduce scan time as much as possible.
Consequently, potential sources of artifacts include fetal and peristaltic motion. Further
investigation is needed to determine if respiratory gating reduces artifacts sufficiently to justify the
additional scan time. Future work leveraging more highly parallelized acquisitions and sparse
imaging methods may also be needed to increase spatial resolution and/or reduce scan time.
This may allow us to robustly image the UtA in the first trimester, compute complex flow
parameters, and provide a larger FOV to capture more distal segments of the ascending UtA later
in pregnancy.

5.2.6 Conclusions
This study shows the feasibility to characterize UtA anatomy and hemodynamics using 4D flow
MRI in second and third trimester pregnancies. Expected flow characteristics were validated
across GA with no observed bias with respect to transabdominal Doppler US.
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CHAPTER 6: PATHOPHYSIOLOGY OF HYPERTENSIVE
PREGNANCY DISORDER AS ASSESSED USING NON-INVASIVE
IMAGING
6.1 Review of US assessment of uterine artery to screen for HPD
Screening studies have been conducted to assess the utility of uterine artery Doppler ultrasound
for predicting the development of HPD. Despite high specificity and high negative predictive
value, uterine artery Doppler ultrasound had poor positive predictive value, meaning that many
women with abnormal uterine artery waveforms had normal pregnancies. It also had poor
sensitivity, especially missing women who would develop late-onset preeclampsia [139, 168].
More recently, researchers sought to improve upon screening for HPD in the first trimester by
developing multi-parametric models combining uterine artery Doppler ultrasound with maternal
factors and serum biomarkers [16, 17]. However, this approach is still under investigation. The
following study begins to examine the performance of MRI-based uterine artery assessment in
relation to clinical outcome and compares it to the performance of ultrasound. Uterine artery flow
measured by MRI was significantly lower in pregnant women with preeclampsia and/or small-forgestational age deliveries than in normal pregnant women.

6.2 Uterine artery assessment by 4D flow MRI in association with delivery
outcomes
6.2.1 Abstract
Clinical assessment of uterine artery (UtA) hemodynamics is currently limited to ultrasound (US)
Doppler velocimetry. We previously demonstrated the feasibility of 4D flow magnetic resonance
imaging (MRI), which allows flow quantification throughout the entire vessel, to evaluate UtA
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hemodynamics during pregnancy. In this study, we seek to further validate the physiologic
relevance of 4D flow MRI measures of UtA blood flow rate by exploring their associations with
pregnancy outcomes relative to US-based metrics.
This was a cross-sectional study of 87 singleton pregnant women, enrolled between May 2016
and April 2019, who underwent a 4D flow MRI scan to measure UtA pulsatility index (PI) and
blood flow rate (in mL/min). UtA PI was also measured using US. The primary outcome was a
composite (COMP) of either preeclampsia (PEC), small for gestational age (SGA), or both
PEC+SGA. The secondary outcomes were PEC and SGA individually. Wilcoxon rank-sum tests
were performed to study the ability of MRI-flow, MRI-PI, and US-PI to distinguish between no
disease versus disease. Linear regression was also performed to study MRI-flow versus
gestational age (GA).
Of the 74 subjects that were analyzed, 18 subjects were COMP: PEC (n=3), SGA (n=11), and
both PEC+SGA (n=4). Additionally, one subject excluded from the analysis had an intrauterine
fetal demise (IUFD). When comparing subjects with and without COMP, no differences in
maternal age, body mass index (BMI), nulliparity, gravidity, or race were found. In 66 of the 74
subjects US data was also available. Both median MRI-PI (0.95 vs. 0.70, p<0.01) and median
US-PI (0.95 vs. 0.73, p<0.01) were significantly increased in subjects with COMP compared to no
COMP. UtA blood flow rate, as measured by MRI, did not significantly increase from 2

nd

to 3

rd

trimester (median flow [interquartile range]=543[419,698] vs. 575[440,746] mL/min, p=0.77), but it
was significantly lower in COMP compared to no COMP (median flow [interquartile
range]=486[366,598] vs. 623[457,749] mL/min, p=0.04). The AUCs for MRI-flow, MRI-PI, and USPI in predicting COMP were comparable (0.69, 0.74, and 0.73) with non-significant differences
among the three AUCs (p=0.87).
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4D flow MRI can yield physiologic measures of UtA blood flow rate and PI that are associated
with adverse pregnancy outcomes. This may open new avenues in the future to explore more
robust MRI-based evaluation of UtA hemodynamics in pregnancy.

6.2.2 Introduction
Doppler ultrasound (US) assessment of the maternal uterine arteries (UtAs) has shown promising
results for predicting risk of adverse pregnancy outcomes [16, 17], but the multiparametric models
required for these assessments are more complex than current clinical US practice. US also has
inherent limitations, such as its sensitivity to the angle between the device and the interrogated
flow direction, that preclude accurate and reproducible assessment of UtA remodeling and
hemodynamic function during pregnancy [141]. The Nulliparous Pregnancy Outcomes Study:
Monitoring Mother-to-be (nuMoM2b) study found UtA Doppler US to have low positive predictive
value in predicting small-for-gestational-age neonates [18]. Other studies have reported variable
results depending on gestational age of onset of preeclampsia [169] and superimposed fetal
growth restriction [170]. Mounting evidence suggests that some women with abnormal
trophoblast invasion have normal UtA Doppler waveforms while others with abnormal UtA
Doppler waveforms have healthy deliveries [171, 172]. Thus, a more robust tool to investigate
UtA remodeling and hemodynamics during pregnancy is still needed.
Four-dimensional (4D) flow magnetic resonance imaging (MRI) time-resolves each component of
the blood flow velocity vector along with morphological data in a single, non-invasive, non-ionizing
scan [173]. This is advantageous given the complex hemodynamic nature in various
cardiovascular conditions. Therefore, it has successfully been used to measure advanced
parameters such as pressure and wall shear stress [158, 174-176]. During pregnancy, a key
advantage of 4D flow MRI is its large spatial coverage allowing for evaluation of the entire course
of the UtA. We previously demonstrated that this modality is technically feasible in pregnant
women [150] but did not correlate UtA flow measurements with pregnancy outcomes. In this
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study, we sought to further validate the 4D flow MRI measures of UtA blood flow by exploring the
association of these measures with adverse pregnancy outcomes and by comparing these
associations with similar associations drawn from Doppler US.

6.2.3 Methods
6.2.3.1 Study participants
A total of 87 singleton pregnant subjects were enrolled between May 26, 2016 and April 25, 2019
in this cross-sectional study approved by the institutional HIPAA-compliant Institutional Review
Board. Inclusion criteria included singleton gestations at 15 weeks or greater. Exclusion criteria
were: (1) morbid obesity (pre-gravid BMI ≥ 35), (2) major structural fetal anomaly, (3) routine MRI
contraindications such as metallic implants/devices and claustrophobia. For some analyses
involving comparison with outcomes, subjects lost to follow-up after MRI were not included, and
subjects with intrauterine fetal demise (IUFD) were analyzed separately from deliveries after 24
weeks with neonates that reached viability. Only subjects whose pregnancies reached viability
and whose obstetric outcomes were available were included in analyses comparing MRI to
pregnancy outcomes. For analyses involving associations between US-pulsatility index (PI) and
pregnancy outcomes, subjects without US scans were not included. Pregnancy outcomes were
extracted from the medical record. The primary outcome was a composite (COMP) of either or
both preeclampsia (PEC), as defined by the American College of Obstetricians and
Gynecologists criteria [78], and small for gestational age (SGA) defined as birth weight <10

th

percentile [177]. Secondary outcomes were PEC and SGA individually. Both MRI-PI and MRIflow were each analyzed as predictors of the outcomes, while US-PI was also analyzed as a
predictor of outcome for comparison.
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6.2.3.2 Measurement of PI and flow with 4D flow MRI
Prospective ECG-gated 4D flow MRI [150] at 1.5T (Avanto, Siemens Healthineers, Erlangen,
Germany) was acquired of the UtAs and external iliac arteries near the internal orifice of the
cervix (Fig. 32) using a 12-channel spine and two 4-channel body matrix coils. The sequence
parameters were: flip angle=8°, repetition time/echo time=5.5/3ms, voxel
3

3

size=1.25x1.25x1.25mm , field-of-view=320x200x60mm , bandwidth per pixel=445-455 Hz/pixel,
segments/shot=2, temporal resolution=42.4-46.4ms, acceleration factor=4.7, velocity encoding
(VENC)=100 cm/s, number of cardiac phases=10-18, and scan time=12-20 minutes depending
on subject’s heart rate. Noise was removed from the velocity maps with thresholding and four
planes distributed along each vessel were manually prescribed to extract velocity maps at each
plane location (Ensight, CEI; Apex, NC). On each velocity map, the UtA was manually contoured
using custom software (Matlab; The MathWorks, Natick, MA, USA). MRI-PI was computed from
the spatial maximum MRI velocity waveforms as !" = (%&'( -%&*+ )/% and averaged across the
four planes for each vessel, where !"#$ =temporal maximum velocity, !"#$=temporal minimum
velocity, and ! =temporal mean velocity. UtA flow rate (mL/min) was computed from the spatial
mean MRI velocity waveforms and vessel cross-sectional area and averaged across the four
planes for each vessel (Fig. 32). More details about the MRI acquisition, post-processing
procedure, repeatability of 4D flow MRI scans, and interobserver reproducibility of postacquisition measures were previously described [150].
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Figure 32 Diagram outlining methodological workflow: a) MRI localizer, b) time-of-flight
MRI angiogram, and c) 4D flow MRI were collected from UtAs. 4D flow post-processing
consisted of extracting velocity waveforms from each plane (example for Plane R1 shown
in (d)). e) Transabdominal Doppler US was collected from the UtAs. MRI-flow was
computed by multiplying cross-sectional area (CSA) by mean velocity (!) from 4D flow
data. MRI-PI and US-PI were computed from 4D flow MRI and US waveforms, where
vmax=systolic maximum velocity and vmin=diastolic minimum velocity. For each subject,
MRI-flow was averaged across four planes in each UtA and added together for total
bilateral MRI-flow used in subsequent statistical analysis. MRI-PI and US-PI were also
averaged from repeated measurements or planes and additionally averaged from both
UtAs.

6.2.3.3 Measurement of PI with Doppler US
Each subject was positioned in semi-recumbent supine. The UtAs were scanned using the C4-8
transabdominal probe of a GE Voluson E10 (GE Healthcare, Wisconsin, United States) US
machine by a Maternal Fetal Medicine clinician (Nadav Schwartz, MD) with extensive experience
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in prenatal US. An average of three measurements of UtA Doppler PI values were recorded
bilaterally.

6.2.3.4 Statistical Analysis
MRI-flow, MRI-PI, and US-PI values are reported as median and interquartile range (IQR, 25%75%) or mean and standard deviation (SD). Scatter plots of MRI-flow versus gestational age (GA)
were generated and R-squared calculated from fitting linear regression models. Wilcoxon ranksum test was used to investigate differences in MRI-flow, MRI-PI, and US-PI between the
pregnancies with and without one of the three outcomes (COMP, PEC, and SGA). We also report
adjusted results after accounting for demographic parameters that were statistically significantly
different between COMP and no COMP. In addition, Spearman’s correlation and Wilcoxon
signed-rank test were used to compare between MRI-PI and US-PI. Receiver-operating
characteristics (ROC) curves and the corresponding area under the curve (AUC) were generated
for MRI-flow, MRI-PI, and US-PI across outcomes, and a Wald test was used to compare the
AUC values associated with MRI-PI and US-PI. Statistical significance was considered at p<0.05.
Statistical analysis was performed using Stata 14.2 (College Station, TX).

6.2.4 Results
6.2.4.1 Delivery Outcomes and Exclusions
After recruitment for MRI, 4D flow post-processing, and applying exclusions for analysis, data
from 74 pregnant subjects were analyzed for both UtAs (Fig. 33, Table 10). The remaining
subjects included one with IUFD and 7 subjects lost to follow-up. Of the 74 subjects, 18
developed a COMP outcome, including 3 with PEC, 11 with SGA, and 4 with both. In 66 of the 74
subjects US Doppler data was acquired on the same day as MRI (Fig. 33, Table 11). No
significant demographic differences between COMP and no COMP were found in terms of age,
race, BMI, nulliparity, and gravidity (Table 11). However, in comparison to no COMP subjects, the
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COMP subjects were scanned at later GA and delivered at earlier GA with lower birthweight.
They also had higher rates of chronic hypertension (CHTN). 39 out of the 74 subjects (35 out of
the 66 subjects) were also reported in a previous study [150].

87 subjects recruited from May 26, 2016 to
April 25, 2019, had 4D flow acquired and
analyzed, MRI-PI and MRI-flow measured
Excluded 5 scans because
only one UtA visible

82 subjects had bilateral UtAs measured
Excluded 7 scans because
subjects lost to follow-up (no
outcomes)

Excluded 1 scan with IUFD
to discuss separately from
main statistical analyses

74 subjects had outcomes recorded
Analysis: MRI-flow vs. GA; MRI-flow vs.
outcomes box-and-whisker plots; MRIflow ROC curves

18 subjects developed COMP

56 subjects developed no COMP

Excluded 8 scans because no
US performed

66 subjects additionally received US exam
(including UtAs)
Analysis: MRI-PI, US-PI vs. outcomes
box-and-whisker plots; MRI-PI, US-PI
ROC curves

Figure 33 Diagram of exclusion criteria for analysis

Cohort with
Delivery Info

COMP

No COMP

N (%)

74 (100)

18 (24)

56 (76)

Age (std)

27.5 (6.2)

26.2 (5.9)

27.9 (6.3)
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p-value

0.315

Race

0.223

Black (%)

53 (72)

16 (89)

37 (66)

White (%)

16 (22)

2 (11)

14 (25)

Other (%)

5 (7)

0 (0)

5 (9)

BMI (IQR)

30.2 (26.2-33.3)

30.2 (25.2-34.6)

30.2 (26.2-32.7)

0.99

Nulliparity (%)

41 (55)

9 (50)

32 (57)

0.596

Gravidity (IQR)

2 (1-3)

2 (1-3)

2 (1-3)

0.521

CHTN (%)

6 (8)

4 (22)

2 (4)

0.028*

GDM (%)

6 (8)

2 (11)

4 (7)

0.592

GA at delivery
(IQR)

39.3 (37.9-40.1)

37.3 (37.1-39.0)

39.5 (38.4-40.6)

0.001*

Birthweight (g)
(IQR)

3147.5 (26803620)

2375 (2015-2685)

3310 (3072.53679.5)

0.001*

GHTN (%)

16 (22)

6 (33)

10 (18)

0.165

PEC (%)

7 (9)

7 (39)

0 (0)

0.001*

SGA (%)

15 (20)

15 (83)

0 (0)

0.001*

GA at MRI (IQR)

28.4 (23.6-32.9)

31.6 (25.7-36.4)

26.6 (23.1-31.2)

0.009*

Total Uterine
Artery Flow
(mL/min) - MRI
(IQR)

591.8 (440.9742.5)

486.1 (366.1598.2)

623.8 (456.6748.6)

0.038*

Table 10 Demographic information for subjects with delivery info, divided into subsets
COMP and no COMP. BMI=body mass index, CHTN=chronic hypertension,
GDM=gestational diabetes mellitus, GA=gestational age, GHTN=gestational hypertension,
PEC=preeclampsia, SGA=small-for-gestational age, PI=pulsatility index, %=percentage,
std=standard deviation, IQR=interquartile range (25%-75%), p-values reported from twosample Wilcoxon rank-sum test, *p<0.05
Cohort with
Delivery & US Info

COMP

No COMP

N (%)

66 (100)

15 (23)

51 (77)

Age (std)

28.1 (6.3)

27.2 (6.0)

28.3 (6.4)

Race
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pvalue

0.542
0.289

Black (%)

46 (70)

13 (87)

33 (65)

White (%)

15 (23)

2 (13)

13 (25)

Other (%)

5 (8)

0 (0)

5 (10)

BMI (IQR)

30.6 (26.2-33.4)

31.3 (25.5-35.0)

30.4 (26.2-32.6)

0.493

Nulliparity (%)

34 (52)

6 (40)

28 (55)

0.31

Gravidity (IQR)

2 (1-3)

2 (1-3)

2 (1-3)

0.675

CHTN (%)

6 (9)

4 (27)

2 (4)

0.021*

GDM (%)

6 (9)

2 (13)

4 (8)

0.516

GA at delivery (IQR)

39.1 (37.7-40.0)

37.1 (36.7-39.0)

39.4 (38.3-40.3)

0.001*

Birthweight (g) (IQR)

3142.5 (2685-3640)

2380 (1885-2690)

3350 (30503740)

0.001*

GHTN (%)

16 (24)

6 (40)

10 (20)

0.105

PEC (%)

7 (11)

7 (47)

0 (0)

0.001*

SGA (%)

12 (18)

12 (80)

0 (0)

0.001*

GA at MRI and US
(IQR)

27.4 (23.4-32.9)

31.6 (25.7-36.4)

25.6 (22.6-31.1)

0.013*

Uterine Artery PI,
Right - US (IQR)

0.71 (0.62-0.99)

0.84 (0.71-1.14)

0.69 (0.58-0.96)

0.015*

Uterine Artery PI,
Left - US (IQR)

0.79 (0.67-0.92)

0.91 (0.76-1.67)

0.78 (0.65-0.87)

0.008*

Uterine Artery PI,
mean - US (IQR)

0.78 (0.67-1.03)

0.95 (0.76-1.37)

0.73 (0.64-0.92)

0.007*

Uterine Artery PI,
Right - MRI (IQR)

0.71 (0.58-0.91)

0.91 (0.67-1.08)

0.68 (0.56-0.87)

0.043*

Uterine Artery PI,
Left - MRI (IQR)

0.75 (0.60-0.94)

0.91 (0.70-1.43)

0.73 (0.56-0.84)

0.014*

Uterine Artery PI,
mean - MRI (IQR)

0.75 (0.63-0.94)

0.95 (0.75-1.13)

0.70 (0.61-0.86)

0.006*

Total Uterine Artery
Flow (mL/min) - MRI
(IQR)

616.4 (451.8-748.1)

469.8 (356.4630.4)

648.2 (480.6755.4)

0.023*

Table 11 Demographic information for subjects with delivery and US info, divided into
subsets COMP and no COMP. BMI=body mass index, CHTN=chronic hypertension,
GDM=gestational diabetes mellitus, GA=gestational age, GHTN=gestational hypertension,
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PEC=preeclampsia, SGA=small-for-gestational age, PI=pulsatility index, %=percentage,
std=standard deviation, IQR=interquartile range (25%-75%), p-values reported from twosample Wilcoxon rank-sum test, *p<0.05

6.2.4.2 MRI-flow with GA and Delivery Outcomes
Median total UtA blood flow (sum of left and right UtA flow) was 592 (IQR 441-742) mL/min in the
2

74 subjects. There was no correlation with GA (y=-0.47x+614.67, R <0.01, p=0.91). Fig. 34
shows a scatterplot of MRI-flow values along GA. The subject with IUFD imaged at 15 weeks
gestation had lower flow than the other subjects at 109.5 mL/min with normal US-PI of 1.98 and
MRI-PI of 1.92. When evaluating COMP and no COMP subjects separately, median UtA blood
flow was 486.1 (IQR 598.2-366.1) mL/min in the 18 COMP subjects and 623.8 (IQR 456.6-748.6)
mL/min in the 56 no COMP subjects. As a group, the COMP subjects had slightly lower flow than
the no COMP group, particularly in the second trimester. No correlations between UtA flow and
2

GA were found in the COMP group (y=6.14x+314.75, R =0.06, p=0.34) and no COMP group
2

(y=1.20x+599.67, R <0.01, p=0.82). The two-sample Wilcoxon rank-sum test showed a reduction
in MRI-flow in COMP subjects (p=0.04), with a trend towards reduction when examining PEC
(p=0.08) and SGA (p=0.08) individually. Box-and-whisker plots of MRI-flow in the 74 subjects with
delivery outcomes are available in Fig. 35. After adjusting for GA (at MRI) and CHTN, mean ± SD
MRI-flow was 496.9 ± 54.6 mL/min in COMP and 635.0 ± 29.8 mL/min in no COMP subjects
(p=0.03). In the 18 COMP subjects, there was an average of 40 ± 35 days between the imaging
exam and delivery. In 16 of the 18 subjects, diagnoses of PEC and SGA were recorded at
delivery.
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Figure 34 Scatterplot of MRI-flow vs. GA in 74 pregnant subjects with significantly lower
median total uterine artery flow in no COMP compared to COMP subjects (dashed lines).
Correlation was not found between MRI-flow and GA for all subjects, COMP, and no
COMP. The red “X” indicates the total uterine artery flow of the IUFD subject for visual
comparison.
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Figure 35 In the 74 subjects with delivery outcomes recorded, we present the box-andwhisker plots of MRI-flow showing difference in a) no COMP vs. COMP (p=0.04), b) no
COMP vs. PEC (p=0.08), c) no COMP vs. SGA (p=0.08). In the 66 subjects with US data
available, we present box-and-whisker plots showing difference in d,g) no COMP vs.
COMP by MRI-PI (p<0.01) and US-PI (p<0.01), e,h) no COMP vs. PEC by MRI-PI (p<0.01) and
US-PI (p=0.02), and f,i) no COMP vs. SGA by MRI-PI (p=0.03) and US-PI (p<0.01). Red “X”
shows MRI-flow, MRI-PI, and US-PI for the IUFD subject.
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6.2.4.3 MRI-PI and US-PI with Delivery Outcomes
A comparison between MRI-PI and US-PI showed a moderate Spearman’s correlation with
ρ=0.69 (p<0.01) and significant bias with median MRI-PI=0.75 (IQR 0.63-0.94) and median USPI=0.78 (IQR 0.67-1.03) (p<0.01). Both MRI and US techniques were able to detect increased PI
in the 15 subjects with COMP (out of 66 subjects) (MRI-PI: p<0.01; US-PI: p<0.01) (Fig. 35).
These differences in both MRI and US PI remained significant when looking at PEC (MRI-PI:
p<0.01; US-PI: p=0.02) and SGA (MRI-PI: p=0.03; US-PI: p<0.01) as individual outcomes as well.
After adjusting for GA (at MRI and US) and CHTN, MRI-PI was 1.02 ± 0.07 for COMP and 0.72 ±
0.04 for no COMP (p<0.01); US-PI was 1.23 ± 0.1 for COMP and 0.81 ± 0.05 for no COMP
(p<0.01).

6.2.4.4 MRI-flow, MRI-PI, and US-PI ROC Curves
The ROC AUCs provided by MRI-flow for no COMP, no PEC, and no SGA were 0.66, 0.69, and
0.64, respectively for the 74 subjects (Fig. 36). The AUC values from MRI-PI vs. US-PI for the
following groups in the 66 subjects were also compared. Further, no significant difference was
found between the two modalities: COMP (0.74 vs. 0.73, p=0.94), PEC (0.84 vs. 0.75, p=0.31),
and SGA (0.69 vs. 0.75, p=0.40) (Fig. 37). In Fig. 38, the ROC curves from MRI-flow, MRI-PI, and
US-PI were compared in the 66 subjects which show no significant difference in predicting COMP
(p=0.87).
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Figure 36 MRI-flow ROC curves for: a) no COMP with AUC=0.66, b) no PEC with AUC=0.69,
and c) no SGA with AUC=0.64

Figure 37 ROC curves from MRI-PI for a) COMP with AUC=0.74, c) PEC with AUC=0.84, and
e) SGA with AUC=0.69. ROC curves from US-PI for b) COMP with AUC=0.73, d) PEC with
AUC=0.75, and f) SGA with AUC=0.75.
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Figure 38 Comparison of the ROC curves from MRI-flow, MRI-PI, and US-PI in 66 subjects
for COMP. They show no statistically significant difference (p=0.87).

Figure 39 a) Example of healthy pregnant uterine artery 4D flow MRI pathlines, b)
ultrasound of corresponding uterine artery with panel a, c) example of uterine artery 4D
flow MRI in preeclamptic pregnancy

6.2.5 Discussion
The principal finding of this study is concordance between 4D flow MRI and US in distinguishing
between pregnancies with no COMP and COMP. We successfully applied 4D flow MRI to the
UtAs and found increased MRI-PI in pregnancies that went on to develop SGA and PEC [32, 178114

180], outcomes associated with impaired trophoblastic invasion. US-PI is used to measure UtA
resistance as a reflection of downstream trophoblast invasion [96, 140, 141, 178]. As compared
to US, 4D flow MRI provides the spatial coverage to visualize the length of the UtAs, measure
lumen area, and decompose blood velocity in three orthogonal directions. In this study, both US
and MRI-PI showed similar prediction of adverse outcomes based on ROC analysis. While US is
more accessible, our data suggests that MRI-PI values are physiologically relevant, providing
support for its continued development as a tool for assessing placental health.
We observed that MRI-flow was lower in COMP than no COMP subjects. The no COMP vs.
PEC/SGA group comparisons showed the same trend but sample size may not have been large
enough to demonstrate significance. Elevated UtA PI may be a concern during late pregnancy
because high resistance limits delivery of oxygenated blood to the placenta [96, 140, 141]. UtA
flow is a more direct measurement of perfusion than PI. We previously demonstrated the
feasibility of measuring UtA flow during pregnancy with 4D flow MRI [150]. The one IUFD subject
in our study was found to have low UtA flow despite normal MRI/US-PI compared to the cohort of
live births. Our findings are consistent with the notion that reduced total UtA flow rate to the
placenta is linked to poor pregnancy outcomes. While studies of US-based measurements of UtA
flow have reported lower flow in PEC [181-184] and SGA [185, 186], technical challenges have
precluded clinical use of US-based flow. US is more user-dependent than MRI and sensitive to
body habitus, angle of insonation, and instrument gain artifacts. As lumen diameter is a significant
contributor to accurate flow measurements, flow measurements may be difficult to reproduce
since lumen walls may not be clearly resolved [181]. Furthermore, since the UtAs are often
tortuous, absolute measures such as flow rate that depend on measurement angle are
challenging to interrogate [181].
We did not observe a significant change in MRI-flow with GA, which we previously attributed to
our subject population being imaged only in the second/third trimester [150], since prior work
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suggested that most of the increase in UtA flow occurs in the first trimester [142, 183, 187].
However, several studies have also reported an increase in UtA flow measured by US in the
second and third trimester [63, 155, 188, 189]. Our findings suggest that low MRI-flow measures
are meaningful and associated with adverse pregnancy outcomes, though intersubject
heterogeneity in our population may have weakened the MRI-flow vs. GA relationship in our
cross-sectional study. Although the mean GA at MRI was significantly later for the COMP than no
COMP group (p<0.01, Table 11), this did not mask the effect of significantly lower MRI-flow in
COMP than no COMP (p=0.04). Since GA is a plausible confounder [63, 186], we adjusted the
analysis for GA and significant group differences persisted (p=0.03).
In this study, US-PI showed an absolute positive bias over MRI-PI (p<0.01), consistent with our
previous report [150], which can be attributed to MRI/US differences in spatiotemporal resolution,
subject body positioning, and location of measurement along the UtA. Even though MRI-PI and
MRI-flow AUC performances were comparable to US-PI (Fig. 38), UtA Doppler is still largely an
investigational tool. US-PI has been found to have inconsistent performance especially in first
trimester pregnancy and unselected, low risk populations [18, 168]. In Fig. 39, we show an
example of the 4D flow geometry and pathlines in healthy and PEC subjects. This approach has
the advantage of deeper penetration and larger field-of-view, thus able to more comprehensively
visualize the uterine vessels for localization.
4D flow MRI has been gaining clinical attention, showing utility in assessing various
cardiovascular diseases [173]. For example, 4D flow MRI has been shown to measure wall shear
stress (WSS), which can be utilized as a meaningful tool for assessing and managing intracranial
aneurysms [190, 191]. For our purposes, the pathophysiology of PEC also involves inherent
vessel wall dysfunction [32, 72, 139, 179, 192, 193]. Further development of 4D flow MRI for
assessing the UtAs in pregnancy can lead to clinically impactful tools to aid in risk stratification,
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identifying early signs of pathology, and guiding future clinical trials aimed at exploring potential
preventive and treatment strategies.
Our study had a high percentage of COMP subjects (18/74, 24%) compared to the 10-15%
prevalence of PEC and SGA in the general population, but this is expected because the
University of Pennsylvania serves a community with a large population of black women, and
black race is a risk factor for PEC/SGA [194]. One limitation of this study is that it is crosssectional, making it difficult to distinguish between intersubject variability and gestational MRI-flow
progression. Longitudinal studies can better characterize changes in UtA MRI-PI/flow. Another
limitation is that the 4D flow MRI sequence used in this study had limited spatial (1.25x1.25x1.25
3

mm ; ~3-4 voxels across the UtA diameter) and temporal resolution (42 ms), potentially limiting
the accuracy of PI and flow rate measurements. We measured a median UtA flow of 623 mL/min
in the no COMP subjects, which seemed lower than the values reported by US [63, 186] and 2D
phase contrast MRI [124]. While it appeared possible that US overestimated mean velocity over
the cross-sectional area by sampling the center of the vessel, we may have underestimated flow
by using lower spatial and temporal resolution with a 1.5T rather than the 3T magnetic field
strength used for 2D phase contrast MRI [124]. We believe this was a systematic bias that
affected measurements in both COMP and no COMP subjects and we did demonstrate
repeatability in a previous study [150]. Fortunately, substantial progress in 4D flow MRI is being
made to decrease scan time and improve temporal and spatial resolution [195, 196]. We believe
with optimization and technical improvements 4D flow MRI can potentially be useful earlier in
gestation.

6.2.6 Conclusions
Effective methods to predict risk of adverse pregnancy outcome are critical to obstetric care. This
study demonstrates that 4D flow MRI is comparable to Doppler US in measuring PI and
additionally measures flow. Both PI and flow are able to distinguish between pregnancies with
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PEC, SGA, or both and a reference group. 4D flow MRI is a technique that can serve as the
foundation for more robust tools to better understand the hemodynamics of the UtAs during
pregnancy.
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CHAPTER 7: EXTENDED ANALYSIS OF MATERNAL PELVIC
ARTERY GEOMETRY AND HEMODYNAMICS
7.1 Maternal cardiovascular system in HPD
Consistent with the placental origin hypothesis, some evidence indicates Research that UtA US is
a better predictor of early-onset preeclampsia (diagnosed before 34 weeks or requiring delivery
before 37 weeks) than other forms of HPD [139]. In contrast, the alternative maternal
cardiovascular origin hypothesis may better explain late-onset preeclampsia and other forms of
HPD for which UtA US does not perform as well [72]. It is possible that HPD results when a
mother with cardiovascular disease has difficulty undergoing the significant changes in cardiac
output, blood volume, systemic vascular resistance, and other processes to support the
pregnancy. The fact that preeclampsia patients share many of the same risk factors, signs, and
symptoms as cardiovascular disease patients motivates the value of investigating the maternal
cardiovascular system beyond the uteroplacental network [197]. This chapter discusses two
additional studies that analyze the images collected with 4D flow MRI of the uterine arteries to
better understand the nature of uterine artery structure and hemodynamics. Unlike the previous
chapters, which only discussed the placenta and uterine arteries alone, these studies expand the
scope of the image assessment towards the entire maternal vascular network by also including
descending aorta and external iliac arteries. Time-of-flight angiography (TOF) was performed for
localization of the uterine arteries. However, because of the large field of view and high spatial
resolution, centerline extraction could be extended to quantify length and curvature starting from
the descending aorta to the uterine arteries and external iliac arteries. Furthermore, combining
length information (TOF) and velocity information (4D flow and 2D phase contrast) in the maternal
pelvic network enabled estimation of pulse wave velocity. Pulse wave velocity is relevant to HPD
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research because it is a marker of arterial stiffness, which is a condition commonly suspected in
HPD patients [32].

7.2 Centerline geometry characterizes tortuosity
7.2.1 Abstract
The uterine artery undergoes morphological changes during pregnancy, but little is known about
the gestational progression of the tortuosity and how it is abnormal in HPD. This study developed
an MRI-based technique to quantitatively characterize the length and curvature of the uterine
arteries. Preliminary results show the unilateral length of the UtAs from the bifurcation of the
internal and external iliac arteries to the most inferior point of the UtAs was 144.8±29.7 mm
-1

(range = 89.6-230.9 mm). The RMS curvature was found to be 0.125 ± 0.034 mm (range =
-1

0.064-0.2 mm ) within the same UtA segments. There was a decreasing trend between
2

gestational age and RMS curvature from the bifurcation to the most inferior point of the UtA (R =
0.1, p = 0.007). Geometric parameters characterizing the UtAs based on TOF angiography may
ultimately provide clinically relevant biomarkers of aberrant remodeling in early gestation.

7.2.2 Introduction
During pregnancy, the maternal uterine arteries (UtAs) undergo vasodilation and elongation to
accommodate the gravid uterus and match fetal demand for oxygen and nutrients [46]. Maternal
arterial dysfunction is characteristic of pregnancy disorders such as preeclampsia [168] and
patients have inward smooth muscle hypertrophy, increased wall thickness, and limited
vasodilation at delivery [198]. However, there is limited quantitative information about temporal
remodeling of UtAs. This information may add value to diagnosis and screening of hypertensive
pregnancy disorders [46]. We have shown that noninvasive, non-contrast MRI is feasible for
characterization of UtA anatomy and hemodynamics in humans [199]. Our objective was to
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quantitatively describe the geometry of the pelvic arteries in healthy pregnant subjects using timeof-flight (TOF) MRI angiography. We hypothesize that the UtA lengthens and becomes more
tortuous with gestational age.

7.2.3 Methods
TOF MRI data from 36 healthy pregnant subjects were analyzed (n=23 in the 2

nd

trimester, and

rd

n=13 in the 3 trimester, gestational age range=16 to 39 weeks). The TOF parameters were:
TR=394 ms, TE=4.4 ms, flip angle=50 degrees, and diastolic ECG-gating. The TOF angiogram
was segmented, isosurfaces and centerlines were generated, and length and curvature were
quantified (Fig. 40b). The centerline connected the center points of maximally-inscribed spheres,
approximated by a Voronoi diagram, along the interior of the vessel. The curvature, ! , was
defined as the reciprocal of the radius, r, of the osculating circle ! = # tangent to the centerline
$
in the normal direction using the Frenet reference system (Fig. 40c). Vessel curvature for an
entire vessel was calculated using the root mean squared (RMS) curvature. Pearson’s R
correlation was performed to test for linear correlations between path length, RMS curvature, and
gestational age.

7.2.4 Results
Figure 41a shows the centerline and UtA curvature histograms of a representative subject (Fig.
41b,c). The UtAs formed a tortuous structure, looped superiorly, and crossed the external iliac
arteries towards the placenta at the fundus of the uterus. The unilateral length of the UtAs from
the bifurcation of the internal and external iliac arteries to the most inferior point of the UtAs was
2

144.8±29.7 mm (range = 89.6-230.9 mm). An increasing trend was observed (R = 0.04, p =
0.08) between gestational age and unilateral length (Fig. 42a). The RMS curvature was found to
be 0.125 ± 0.034 mm-1 (range = 0.064-0.2 mm-1) within the same UtA segments. There was a
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decreasing trend between gestational age and RMS curvature from the bifurcation to the most
2

inferior point of the UtA (R = 0.1, p = 0.007; Figure 42b).

Figure 40 a) 3D maximum intensity projection of the TOF angiogram in a representative
subject. The green arrowheads delineate the UtAs after branching from the internal iliac
arteries. b) The isosurface rendering and centerline extraction of the same subject. Red
dots represent the starting landmarks at the bifurcation of the internal and external iliac
arteries. Black dots represent the ending landmarks at the most inferior point of the UtAs.
The path length and root mean squared curvature reported in this study are calculated
from the blue coordinates. C) Diagram of how curvature is computed based on the tangent
osculating circle to a curve. The more tortuous curve has a smaller radius (r) and higher
curvature (κ).
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Figure 41 a) Centerlines of a representative subject with difference in tortuosity between
the left and right UtA. It extends from the descending aorta through the common iliac
arteries, internal iliac arteries, UtAs, and external iliac arteries. Red dots represent the
starting landmarks at the bifurcation of the internal and external iliac arteries. Black dots
represent the ending landmarks at the most inferior point of the UtAs. The curvature
histogram of the right UtA (b) has a narrower distribution than the left UtA (c).
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Figure 42 a) Plot with linear correlation results showing decreasing trend in path length
over gestational age (GA) in the left UtA and right UtA. b) Plot with linear correlation
results showing curvature with decreasing trend with gestational age (GA) in the left UtA
and right UtA.

7.2.5 Discussion
This study demonstrated quantitative characterization of UtA length and curvature geometry
using TOF MRI angiography. Curvature was found to be a quantitatively meaningful descriptor of
UtA tortuosity and could differentiate bilateral UtA anatomical heterogeneity. This may reflect
variations in placental location, viability and distal uterine and spiral arterial remodeling.
Additionally, this study provided important preliminary data regarding the association between
UtA length, curvature and gestational age. It was expected that the UtA path length would
increase during angiogenesis and become more tortuous to accommodate fetal growth and
decreasing blood flow pulsatility. However, we saw a decrease in length and curvature, which
may be because the uterine artery was originally coiled and the expanding uterus causes it to
uncoil. UtA remodeling is believed to rapidly occur within the first two trimesters to anticipate
rd

increased fetal oxygen and metabolic demand, tapering off by 3 trimester [46, 200]. We
observed that path length and curvature vary considerably with laterality. Future work will
investigate curvature and tortuosity in patients with adverse pregnancy outcomes.
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7.2.6 Conclusions
The major contributions of this study are 1) the development of an approach to measuring length
and curvature of the UtAs, and 2) trends toward UtA path length shortening and decreased
tortuosity with gestational age. Additional subjects will confirm that these trends are consistent
with UtA remodeling in animals [46]. This approach is applicable to studying UtA remodeling early
in pregnancy and can be used to investigate the relationship between vascular geometry and
hemodynamics.

7.3 Pulse wave velocity characterizes arterial stiffness
7.3.1 Abstract
Maintenance of blood supply to the placenta is believed to be dependent on the geometric and
hemodynamic properties of the uteroplacental vasculature. In this study we present an MRI
method for measuring pulse wave velocity in the uterine arteries. In 6 healthy pregnant subjects,
we measured path length and time-to-peak of the velocity waveforms in the uterine arteries and
external iliac arteries. The uterine arteries have lower pulse wave velocity than the external iliac
-5

arteries (5.5±2.5 vs. 12.9±4.6 m/s, p=3x10 ), suggesting biomechanically greater compliance.

7.3.2 Introduction
After successfully showing feasibility in human pregnancy, we sought to extend the 4D flow MRI
analysis technique by estimating pulse wave velocity (PWV) in the UtAs. UtA remodeling is
believed to involve increasing arterial compliance to reduce blood flow resistance to the placenta
[138] based on flow-mediated dilation studies and animal models [60, 201-203]. A limitation of
ultrasound-based flow-mediated dilation studies is their inability to visualize the UtAs beyond 3-4
cm in length at a time. In this study, we leveraged time-of-flight (TOF) and 4D flow MRI to
measure and compare PWV measured from the descending aorta (dAo) to the UtAs and external
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iliac arteries (EIAs). To our knowledge, 4D flow MRI measurements of PWV in the UtAs in human
pregnancy have not yet been reported. We hypothesized that the UtAs would have lower PWV
than the EIAs.

7.3.3 Methods
We acquired TOF and 4D flow MRI in 6 healthy singleton pregnant women (gestational age
(GA)=18-25 weeks) at 1.5T (Avanto; Siemens Healthcare, Erlangen, Germany). They were
imaged in supine position with 8-channel spine array, two 4-channel body array coils,
electrocardiogram synchronization. The MRI protocol consisted of a half-Fourier acquisition
stimulated echo (HASTE) to localize the pregnant uterus, TOF angiogram from the dAo to the
femoral heads of the thigh bones, 2D phase contrast velocimetry at the dAo, and 4D flow of the
UtAs (total acquisition time=30-40 min). The TOF parameters were: repetition time (TR)/echo
3

time (TE)=394/4.4 ms, flip angle (FA)=50º, field-of-view (FOV)=350x250x190 mm , voxel
3

size=1.1x1.1x2.8 mm . The 4D flow parameters were: TR/TE=5.5/2.8 ms, FA=8º,
3

3

FOV=320x240x60 mm , voxel size=1.25x1.25x1.25 mm , PEAK-GRAPPA acceleration
factor=4.7 [145], velocity encoding parameter (VENC)=120-160 cm/s [22], number of cardiac
phases=10-18. The TOF angiograms were segmented (Seg3D; Univ. of Utah SCI) and
centerlines were extracted (VMTK) to compute path length (PL) from the dAo to the UtAs and
EIAs. The 4D flow images were processed with custom software (MATLAB) [147] and volumetric
velocity-based thresholding (Ensight, CEI; Apex, NC). Eight planes were prescribed in each
vessel and time-to-peak (TTP) was computed from the velocity waveform extracted from each
plane. PWV was computed by PWV=PL/TTP [m/s]. We used box-and-whisker plots, two-tailed
paired t-test, and two-way ANOVA to compare the PWV results.

7.3.4 Results
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Figure 43 shows the dAo, EIA and UtA blood velocity in one subject at 18 weeks gestation.
Across all subjects, PWV was 5.5±2.5 m/s (mean±std) in the UtAs and 12.9±4.6 m/s in the EIAs
-5

(p=3x10 ). The difference in PWV was 7.4 m/s with 95% confidence interval [5.2,9.6] m/s. Figure
44 shows that the UtAs have lower PWV than the EIAs. When comparing PWV measurements
-4

between vessel type (UtA vs. EIA) and laterality, there was an effect of vessel type (p=3x10 ) but
not in laterality (p=0.42). The UtA and EIA diameters were 6.2±0.7 mm and 8.2±1.0 mm (p=1x10
4

-

), respectively. Table 12 contains the data for each subject.

Figure 43 Vessel isosurface including the descending aorta, UtAs, and EIAs in a subject at
18 weeks gestational age. Only one 2D phase contrast measurement was obtained at the
descending aorta. The remaining red dots indicate approximate locations at which eight
planes were extracted from the 4D flow acquisition. Path length (PL) and time-to-peak
(TTP) were computed and normalized to the reference measurement in the descending
aorta to calculate PWV.
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Figure 44 a) Box-and-whisker plot of individual left and right UtAs and EIAs, b) box-andwhisker plot of UtAs and EIAs with left and right sides averaged together, c) scatter plot
with linear fit of individual left and right UtAs and EIAs, d) scatter plot with linear fit of
UtAs and EIAs with left and right sides averaged together.
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Table 12 Details of each subject. It appears that the longer TTP in the UtA compared to the
EIA is a major contributing factor to the smaller PWV. GA=gestational age, PL=path length,
TTP=time to peak, PWV=pulse wave velocity

7.3.5 Discussion
We found that the UtA PWV was lower than EIA PWV between 18-25 weeks of pregnancy.
According to the Moens-Korteweg equation, this would indicate reduced UtA wall compliance or
wall thickness compared to the EIAs. We speculate PWV decreases with time as UtA wall
compliance increases with gestational remodeling [60]. This response is important in maintaining
low blood flow resistance and high flow rate to the placenta [60]. PWV can potentially be used to
monitor UtA hemodynamics in patients with high risk of hypertensive disorders of pregnancy,
which are believed to reflect systemic endothelial dysfunction [202, 203]. A limitation of 4D flow is
its low temporal resolution compared to the EIA pulse wave transit time (Dt=40 vs. TTP=21 ms).
This was mitigated by selecting a large distance between the reference (dAo) and the UtA/EIA
locations, and measuring PWV at several UtA/EIA locations. Nevertheless, we found that EIA
PWV was slightly higher than previous US studies (9.4-9.8 m/s) [38, 39], which may imply a
combination of inaccurate spatial distance measurements in US and low temporal resolution. A
further limitation of this study is that it assumes inviscid flow since there is no dependence on
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viscosity [204]. Finally, differences in radius between the EIA and UtA may also have contributed
to this trend since the UtAs have a smaller radius than the EIAs. In future work, fluid dynamic
simulations and increase in spatial resolution of 4D flow would aid in better understanding of the
viscous interactions between the blood flow and the arterial wall. A longitudinal study can better
investigate the change in UtA PWV with gestational age.

7.3.6 Conclusions
The major contribution of this work is a joint structural-functional approach to assessing PWV in
pregnant women. Physiologic changes in the female pelvic vasculature are believed to reflect
pregnancy health during the course of gestation. Therefore, PWV may be a potential biomarker of
UtA remodeling during clinical monitoring for adverse pregnancy outcomes.
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CHAPTER 8: CONCLUSIONS, LIMITATIONS, AND FUTURE
DIRECTIONS
8.1 Conclusions
Today, the mechanisms of HPD are under investigation and early prediction of adverse
pregnancy outcomes continues to be a challenge. This motivates researchers to continue
developing technologies that can noninvasively study human placental physiology and to provide
biomarkers that can be used in clinical diagnosis and management. This dissertation contributes
to this effort by exploring how current MRI flow and perfusion methods already successful in the
brain and cardiovascular system can be applied to the uteroplacental circulation. The evidence
presented in this thesis shows the feasibility of MRI in human pregnancy by addressing
challenges such as motion and extracting functional information from small vessels. These
studies also explored innovative ways to characterize the uteroplacental structure and function by
developing visualizations and metrics based on these imaging techniques.
Chapter 4 described the application of arterial spin labeling (ASL) to the placenta, the key organ
of nutrient exchange between the mother and fetus. However, placental MRI is susceptible to
motion artifacts from respirations, contractions, and fetal movement. This study of FAIR ASL was
affected by these artifacts, but it showed promise as images processed by traditional methods
demonstrated the expected pattern of perfusion. After establishing the feasibility of placental ASL,
the need for a novel pattern analysis approach to more accurately capture the unique physiology
of the placenta was identified. The combination of Bayesian statistics, spline-based coordinate
transformation, and cluster analysis showed blood distribution aggregates reminiscent of the
known lobular structure of the placenta. This work opens the door for future investigation in the
ability of ASL cluster analysis to distinguish between hypertensive and normal pregnancies.
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In response to the numerous uterine artery Doppler flow velocimetry studies to evaluate
pregnancy health, especially the risk of HPD, Chapter 5 described the application of 4D flow MRI
to the uterine arteries in human pregnancy. 4D flow MRI enabled 3D pathline visualization of
blood flow in the tortuous vessels, extraction of time-resolved 2D velocity fields at vessel cross
sections, calculation of flow rate, pulsatility index (PI), and resistivity index (RI). By comparison,
corresponding ultrasound PI and RI moderately agreed with MRI. The other information such as
flow rate were believed to be more reliable in MRI and generate interest in further investigation of
complex flow properties that may be more physiologically relevant than PI and RI (Chapter 7).
Chapter 6 correlated information from 4D flow MRI of the uterine arteries with pregnancy
outcomes to see if this technique can detect the difference between preeclampsia/small for
gestational age and normal pregnancies. It was shown to perform successfully and similarly to
ultrasound PI. This establishes the validity of 4D flow MRI and the value of further technical
improvement to leverage the additional complex hemodynamic information unique to this method
for HPD research.
Chapter 7 explored cardiovascular physiology extending beyond the uteroplacental vessels.
Time-of-flight (TOF) MRI angiography originally used for localization of the uterine artery also
captured a large field of view including the descending aorta through the external iliac
arteries/uterine arteries. It was also apparent that the uterine arteries had a unique tortuous
structure that was probably an adaptation to the expanding uterus. To aid exploration, centerline
extraction from the TOF MRI was performed and followed by calculation of path length and
curvature. Path length information combined with velocimetry of the aorta (2D phase contrast
MRI) and uterine artery/external iliac artery (4D flow MRI) enabled estimation of pulse wave
velocity (PWV). Since arterial stiffness of endothelial dysfunction has been identified as a
potential biomarker of HPD and PWV is known to be related to arterial stiffness, this technique of
measuring PWV was developed to examine possible correlation with adverse pregnancy
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outcomes. Results show promise as PWV was found to be higher in the external iliac arteries
than the uterine arteries, which is consistent with the expectation that the former vessels would
be stiffer.

8.2 Limitations
There are several limitations to the version of ASL presented in Chapter 4. First, the sequence
was a 2D multislice technique that had a 2.5 mm slice gap and only four 10 mm slices, which
meant that there was incomplete coverage of the placenta. An accelerated 3D version of ASL
would be needed to assess the entire intervillous space for maternal vascular malperfusion
abnormalities. Second, the post-label delay time points were sparse, only 2 to 4 points between
500 to 2000 ms. By these times, most of the blood has reached steady state in the intervillous
space. To capture perfusion dynamics, shorter post-label delays would have been needed (<150
ms). Third, this study was conducted at 1.5 T MRI field strength, which compared to 3T limited
the amount of perfusion signal distinguishable from physiological noise. Fourth, there was a small
sample size when correlating adverse pregnancy outcomes with the cluster based metrics, so a
larger sample size would be needed to confirm that the cluster metrics are related to placental
health.
One of the limitations of the UtA 4D flow MRI studies presented in Chapter 5 and Chapter 6 was
that it was cross-sectional, which made the results vulnerable to physiologic variation (e.g. height,
weight, and internal iliac branching geometry). This can be mitigated with a longitudinal study to
track flow changes over time for each subject. Also, the accuracy of 4D flow MRI assessment of
UtA function may have been limited by UtA tortuosity, causing MRI acceleration and
displacement artifacts. The findings were also limited by spatial resolution. Even when the UtA
was visible in pregnant subjects, three voxels spanned the vessel at best, which did not allow the
calculation of interesting complex hemodynamic parameters such as pressure gradient or wall
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shear stress. Limited temporal resolution also made it difficult to identify detailed features of the
UtA velocity waveforms such as diastolic notch in ultrasound.
The centerline extraction and pulse wave velocity studies described in Chapter 7 were proof-ofconcept and had several limitations. The centerline geometry did not contain the other branches
of the internal iliac arteries which may be important for understanding the structure of the UtAs
relative to the other vessels. The path lengths were denoted as ending at the most inferior point
of the “hairpin loop” of the UtAs before they ascended along the side of the uterus, but this
missed part of the tortuous segment immediately after the inferior point. The end point may have
also been slightly arbitrary because the extent of the visible UtAs transitioning to arcuate arteries
was limited by vessel size and time-of-flight MR image quality. The path length and curvature
versus gestational age correlations may have been confounded by other factors including
maternal height, maternal weight, fetal weight, and body habitus during MRI scan.
A limitation of the PWV study was that the time shift of the UtA and external iliac artery velocity
waveforms relative to the aorta velocity waveform was calculated based on peak velocities.
Ideally the time shift should be measured between the “foot” (minimum velocity immediately after
the peak) of each waveform in order to avoid wave reflections interfering with the time shift of the
forward wave. However, this was not feasible with the current 4D flow MRI sequence because of
low temporal resolution. Another consequence of low temporal resolution was that a large
distance between the starting and the end velocity measurements was required to estimate global
PWV. Therefore, even though the aorta, UtAs, and external iliac arteries were expected to have
different vessel wall properties, local PWV could not be calculated with this technique. Both
centerline extraction (path length and curvature) and PWV studies did not have a gold standard to
evaluate accuracy.
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8.3 Future Directions
Placental ASL MRI can be further improved upon by implementing 3D full coverage of the
placenta using simultaneous multi slice imaging and by performing studies at 3 Tesla to increase
sensitivity [24]. This would allow three-fold acceleration of the scan to acquire the images in a
reasonable amount of time while capturing perfusion dynamics with multiple post-label delays. To
mitigate the risk of slice order introducing bias into the ASL image contrast, slice shuffling can be
used to average out these slice order effects. New labeling strategies can be tested to see if they
can overcome the inflexible localization of labeled blood, the main limitation in FAIR ASL. Also,
the ASL-related patterns can be correlated with placental oxygenation techniques such as BOLD
MRI and T2* mapping. The placental pattern analysis can be improved upon by parameterizing
the distance from the maternal to fetal side. This would make blood distribution characterization
more precise when comparing between subjects. For validation, the in vivo patterns captured by
ASL MRI could be mapped to post-delivery placental pathological features. In HPD, the key signs
of maternal vascular malperfusion include placental hypoplasia, accelerated villous maturation,
and decidual arteriopathy.
The UtA 4D flow MRI can be improved by conducting a longitudinal study to distinguish between
intersubject variability and gestational MRI-flow progression. The MRI sequence can be
accelerated using recent innovations such as 3D radial readout trajectory [195], spiral trajectory
[205], and compressed sensing [205]. A shorter scan time (<10 min.) increases comfort for the
pregnant subject lying supine and decreases the risk of motion introducing artifacts in the images.
Acceleration can also achieve better image quality, reaching 15 ms temporal resolution and
3

<1x1x1 mm spatial resolution. Also, since the prospective gating causes the scan to miss some
end-diastolic cardiac phases per cycle, implementing retrospective reconstruction can lead to
more accurate calculations of hemodynamic parameters. These improvements may allow 4D flow
MRI to be more suitable for assessing the UtAs earlier in gestation.
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There are various ways to improve upon the time of flight MRI centerline analysis of the maternal
pelvic arteries. The main limitation of the current study was that the path length and curvature
versus gestational age analyses were cross-sectional and therefore susceptible to confounding
factors. These factors include maternal height, maternal weight, fetal weight, and body habitus
during MRI, which should be considered in a future study because they can potentially affect
uterine artery path length and curvature. A future longitudinal study of how path length and
curvature change over gestation in each subject may help better understand the involvement of
vessel geometry in the physiological adaptation of pregnancy without interference of intersubject
variability. Additional MRI vessel wall imaging of the uterine arteries can enable investigation of
the vessel wall changes involved during gestation. A recent study [206] reported mathematical
modeling of the spiral geometry of the spiral arteries to simulate its effect on flow rate and
resistance. It was found that increased complexity in the structure of the vessel increased
resistance to flow while decreasing flow rate. Similar analysis can be applied to the uterine
arteries to better understand the physiological remodeling process during pregnancy.
Improvements can be made to the PWV study. In the future, ultrasound-based measurement of
PWV can be used as a baseline reference to validate MRI-based PWV. Alternatively, a
repeatability of the 4D flow MRI-based PWV can be used to test for robustness of the method.
The main concern of the 4D flow MRI sequence was the low temporal resolution, so future
studies should leverage state-of-the-art acceleration and reconstruction techniques to reduce
measurement error. An experimental phantom such as the one described by Ruesink et. al. [207]
can be used to model uterine artery mechanical properties to monitor their effect on
hemodynamics including PWV. Computational fluid dynamics can also serve a similar purpose by
modeling the uterine artery geometry, mechanical properties, and hemodynamics
computationally.
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8.4 Summary
This dissertation describes the application of ASL and 4D flow MRI to investigate the blood
supply to the placenta during pregnancy. ASL MRI was found to be sensitive to blood flow
patterns in the placenta that were consistent with structure of the intervillous space and lobular
arrangement. 4D flow MRI was found to successfully measure flow rate in the uterine arteries, a
parameter which was predictive of adverse pregnancy outcomes. Path length, curvature, and
PWV of uterine arteries were additional parameters that were found to be measurable with MRI.
They can potentially be relevant biomarkers of HPD. MRI is a noninvasive technique that offers
potential to better characterize the physiological changes in pregnancy and, with further
development, become a useful clinical tool for risk assessment in HPD.
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